Faculty Collaboration Database

1. Hematti P, Keating A. (editors) “Mesenchymal stromal cells: Biology and clinical applications” Publisher: Elsevier, First edition: 2013

2. Viswanathan S, Hematti P. (editors) “Mesenchymal Stromal cells: Translational Pathways to Clinical Adoption” Publisher: Academic Press, First edition: 2016

3. Schmuck E, Hematti P, Raval A. (editors) “Cardiac Extracellular Matrix: Fundamental Science to Clinical Applications” Publisher: Springer Nature, First Edition, 2018.

4. Hematti P, Lessin LS. ”Porphyria” published in: “The Bethesda Handbook of Clinical Hematology” (1st edition); Rodgers GP, Young NS (editors): 2004

5. Hematti P, Lessin LS. ”Porphyria” published in: “The Bethesda Handbook of Clinical Hematology” (1st edition); Rodgers GP, Young NS (editors): 2004

6. Hematti P. “Porphyria” published in: “The Bethesda Handbook of Clinical Hematology” (2nd edition); Rodgers GP, Young NS (editors): 2009

7. Battiwalla M, Hematti P. “Myelodysplastic Syndromes” published in: “Conn’s Current Therapy 2010”; Rakel RE, Bope ET, Kellerman R (editors) 2010

8. Hematti P. “Human embryonic stem cell derived mesenchymal progenitors: An overview” published in: “Methods in Molecular Biology”; zur Nieden NI (editor) 2011

9. Hematti P, Kim J, Battiwalla M. “Mesenchymal Stem Cells in Hematopoietic Stem Cell Transplantation” published in: “Stem Cells and Human Diseases”; Srivastava R and Shankar S (editors) 2012

10. Hanson S, Hematti P. “Clinical Applications of Cell-Biomaterial Constructs for Tissue Reconstruction” I published in: “Biomaterials and Stem Cells in Regenerative Medicine”; Ramalingam M, Ramakrishna S, Best S (editors) 2012

11. Hematti P, Hanson S. “Immunobiology of Biomaterial-Mesenchymal Stem Cell Interactions” published in: “Biomaterials and Stem Cells in Regenerative Medicine”; Ramalingam M, Ramakrishna S, Best S (editors) 2012

12. Hematti P, Keating A. “Mesenchymal stromal cells in regenerative Medicine: A perspective” published in “Mesenchymal stromal cells: Biology and clinical applications”; Hematti P, Keating A. (editors). 2013

13. Hematti P. “Porphyria” published in: “The Bethesda Handbook of Clinical Hematology” (3nd edition); Rodgers GP, Young NS (editors) 2013

14. Hematti P. “Mesenchymal Stem Cell Transplantation: From Tissue Regeneration to Immune Modulation” published in: “Stem Cell Handbook”. (2nd edition) Sell S. (editor) 2013

15. Kim J, Hematti P. “Harnessing Regenerative and Immunomodulatory Properties of Mesenchymal Stem Cells in Transplantation Medicine” published in: “Principles of Regenerative Medicine and Cell, Tissue, and Organ Bioengineering”. Orlando G, Lerut JP, Soker S, Stratta RJ. (editors) 2014

16. Hematti P. “Mesenchymal Stromal Cells: Clinical Experience, Challenges, and Future Directions” published in: “Mesenchymal Stromal cells: Translational Pathways to Clinical Adoption” Viswanathan S, Hematti P. (editors) 2016

17. Bouchlaka MN, Hematti P, Capitini CM. “MSC Therapy: defining the risks of MSC therapy” published in “Mesenchymal Stromal Cells as Tumor Stromal Modulators”. Bolontrade MF and García MG and (editors) 2017

18. Hematti P. “Porphyria” published in: “The Bethesda Handbook of Clinical Hematology” (4th edition); Rodgers GP, Young NS (editors) 2018

19. Hematti P. “Role of Extracellular Matrix in Cardiac Cellular Therapies” published in “Cardiac Extracellular Matrix: Fundamental Science to Clinical Applications” Schmuck E, Hematti P, Raval A. (editors): 2018

20. Denu RA, Hematti P. “Sirtuins and stem cell maintenance, proliferation, and differentiation.” Published in “Sirtuin Biology in Medicine: Targeting New Avenues of Care in Development, Aging, and Disease”. Kenneth Maiese (editor) 2021

1. Fine HF, Akin C, Hematti P, Butman J, Caruso RC, Csaky KG, Metcalfe DD, Nussenblatt RB, Robinson MR. Presumed choroidal and orbital mastocytosis. Archives of Ophthalmology. 119(11):1716-1719, 2001. PMID: 11709028. PMCID Policy Exempt: Accepted prior to April 7, 2008

2. Galipeau J, MAURO Krampera M, Barrett J, Dazzi F, Deans RJ, DeBruinjn J, Dminici M, Fibbe WE, Gee AP, Gimble JM, Hematti P, Koh MBC, LeBlanc K, Martin I, McNiece IK, Mendicino M, Oh S, Ortiz L, Phinney DG, Planat V, Prockop DJ, Shi Y, Stroncek DF, Viswanathan S, Weiss DJ, Semsebe L. ISCT perspective on immune functional assays for Mesenchymal Stromal Cells as potency release criterion for advanced phase clinical trials. Cytotherapy. 2016 Feb;18(2):151-9. PMID: 26724220

3. Kenkre VP, Bradley K, Milton A, Burkholder JK, Grindle K, McMannes J, Kim K, Callander N, Juckett M, Longo W, Hematti P. TCR-α/β and CD19 depleted stem cell grafts from haploidentical donors for allogeneic transplantation in patients with relapsed lymphoma: a single-center experience. Leuk Lymphoma. 2023 Aug 10:1-5. Online ahead of print. PMID: 37585704

4. Shi PA, Hematti P, von Kalle C, Dunbar CE. Genetic marking as an approach to studying in vivo hematopoiesis: progress in non-human primate model. Oncogene 21(21): 3274-3283, 2002. PMID: 12032769. PMCID Policy Exempt: Accepted prior to April 7, 2008

5. Hematti P, Sloand EM, Carvallo CA, Albert MR, Yee CL, Fuehrer MM, Blancato JK, Kearns WG, Barrett JA, Childs RW, Vogel JC, Dunbar CE. Absence of donor-derived keratinocyte stem cells in skin tissues cultured from patients after mobilized peripheral blood hematopoietic stem cell transplantation. Experimental Hematology 30(8):943-949, 2002. PMID: 12160846. PMCID Policy Exempt: Accepted prior to April 7, 2008

6. Hematti P, Sellers SE, Agricola BA, Metzger ME, Donahue RE, Dunbar CE. Retroviral transduction efficiency of G-CSF+SCF mobilized peripheral blood CD34+ cells is superior to G-CSF or G-CSF+Flt3-L mobilized cells in nonhuman primates. Blood 101(6):2199-2205, 2003. PMID: 12424191. PMCID Policy Exempt: Accepted prior to April 7, 2008

7. Hematti P, Tuchman S, Larochelle A, Metzger ME, Donahue RE, Tisdale JF. Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates. Stem Cells 22(6):1062-1069, 2004. PMID: 15536196. PMCID Policy Exempt: Accepted prior to April 7, 2008

8. Kiem HP, Sellers S, Thomasson B, Morris JC, Tisdale JF, Horn PA, Hematti P, Adler R, Kuramoto K, Calmels B, Bonifacino A, Hu J, Von Kalle C, Schmidt M, Sorrentino B, Nienhuis A, Blau CA, Andrews RG, Donahue RE, Dunbar CE. Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia. Molecular Therapy 9(3):389-395, 2004. PMID: 15006605. PMCID Policy Exempt: Accepted prior to April 7, 2008

9. Kuramoto K, Follmann DA, Hematti P, Sellers S, Agricola BA, Metzger ME, Donahue RE, Von Kalle C, Dunbar CE. Effect of chronic cytokine therapy on clonal dynamics in non-human primates. Blood 103(11):4070-4077, 2004. PMID: 14962906. PMCID Policy Exempt: Accepted prior to April 7, 2008

10. Hanawa H, Hematti P, (first co-author) Keyvanfar K, Metzger ME, Krouse A, Donahue RE, Kepes S, Gray J, Dunbar CE, Persons DA, Nienhuis AW. Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system. Blood 103(11):4062-9, 2004. PMID: 14976042. PMCID Policy Exempt: Accepted prior to April 7, 2008

11. Hematti P. Modeling human hematopoietic stem cell gene therapy in nonhuman primates. Current Hematology Report 3(4):282-289, 2004. PMID: 15217558. PMCID Policy Exempt: Accepted prior to April 7, 2008

12. Kuramoto K, Follman D, Hematti P, Sellers S, Laukkanen MO, Seggewiss R, Metzger ME, Krouse A, Donahue RE, Von Kalle C, Dunbar CE. The Impact of low-dose Busulfan on clonal dynamics in non-human primates. Blood 104(5):1273-1280, 2004. PMID: 15126320. PMCID Policy Exempt: Accepted prior to April 7, 2008

13. Hematti P, Hong BK, Ferguson C, Adler R, Hanawa H, Sellers S, Holt IE, Eckfeldt CE, Sharma Y, Schmidt M, von Kalle C, Persons DA, Billings EM, Verfaillie CM, Nienhuis AW, Wolfsberg TG, Dunbar CE, Calmels B. Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. PLoS Biology 2(12): e423, 2004. PMID: 15550989. PMCID: PMC529319. PMCID Policy Exempt: Accepted prior to April 7, 2008

14. Hematti P, Obrtlikova P, Kaufman DS. Nonhuman primate embryonic stem cells as a preclinical model for hematopoietic and vascular repair. Experimental Hematology 33(9):980-986, 2005. PMID: 16140145. PMCID Policy Exempt: Accepted prior to April 7, 2008

15. Calmels B, Ferguson C, Laukkanen MO, Adler R, Faulhaber M, Kim HJ, Sellers S, Hematti P, Schmidt M, von Kalle C, Akagi K, Donahue RE, Dunbar CE. Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells. Blood 106(7):2530-2533, 2005. PMID: 15933056. PMCID: PMC1895268

16. Larochelle A, Krouse A, Metzger M, Orlic D, Donahue RE, Fricker S, Bridger G, Dunbar CE, Hematti P. AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in non-human primates. Blood 107(9):3772-3778, 2006. PMID: 16439684. PMCID: PMC1895780

17. Trivedi P, Hematti P. Simultaneous generation of CD34+ primitive hematopoietic cells and CD73+ mesenchymal stem cells from human embryonic stem cells cocultured with murine OP9 stromal cells. Experimental Hematology 35(1):146-154, 2007. PMID: 17198883. PMCID Policy Exempt: Accepted prior to April 7, 2008

18. Trivedi P, Hematti P. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Experimental Hematology 36(3):350-359, 2008. PMID: 18179856. PMCID: PMC2315792

19. Hematti P. Role of mesenchymal stromal cells in solid organ transplantation. Transplantation Reviews 22(4): 262-73, 2008. PMID: 18656340. PMCID: PMC2576746

20. Battiwalla M, Hematti P. Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy 11(5):503-15, 2009. PMID: 19728189. PMCID: PMC2766085

21. Liu YP, Hematti P. Generation of mesenchymal stromal cells from HOXB4-expressing human embryonic stem cells. Cytotherapy 11(6):716-25, 2009. PMID: 19878058. PMCID: PMC2774218

22. Laurila JP, Laatikainen L, Castellone MD, Trivedi P, Heikkila J, Hinkkanen A, Hematti P, Laukkanen MO. Human embryonic stem cell derived mesenchymal stromal cell transplantation into rat hind limb injury enhances angiogenesis. Cytotherapy 11(6):726-737, 2009. PMID: 19878059. PMCID: PMC2889035

23. Kim YJ, Kim YS, Larochelle A, Renaud G, Wolfsberg TG, Adler R, Donahue RE, Hematti P, Hong BK, Royaei J, Akagi K, Riberdy JM, Nienhuis AW, Dunbar CE, Petersons DA. Sustained high level polyclonal hematopoietic marking and transgene expression four years following autologous transplantation of rhesus macaques with SIV lentiviral vector transduced CD34+ cells. Blood 113(22):5434-5443, 2009. PMID: 19339698. PMCID: PMC2689045

24. Kim J, Hematti P. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Experimental Hematology 37(12):1445-53, 2009. PMID: 19772890. PMCID: PMC2783735

25. Hanson S, Bentz M, Hematti P. Mesenchymal stem cell therapy for non-healing cutaneous wounds. Plastic and Reconstructive Surgery 125(2):510-516, 2010. PMID: 20124836. PMCID: PMC4076140

26. Hanson S, Kim J, Quinchia Johnson BH, Bradley B, Breunig JM, Hematti P (co-corresponding author), Thibeault SL. Characterization of Mesenchymal Stem Cells from Human Vocal Fold Fibroblasts. Laryngoscope 120(3):546-551, 2010. PMID: 20131365. PMCID: PMC2829335

27. Markovina S, Callander NS, O’Connor SL, Xu G, Shi Y, Leith CP, Kim K, Trivedi P, Kim J, Hematti P, Miyamoto S. Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-kB activity in myeloma cells. Molecular Cancer 9(176) 2010. PMID: 20604947. PMCID: PMC3095250

28. Hanson S, Thibeault SL, Hematti P. Clinical Applications of mesenchymal stem cells in laryngotracheal reconstruction. Current Stem Cell Research & Therapy. 1;5(3):268-72, 2010. PMID: 19951250. PMCID: PMC3167577

29. Hanson SE, Gutowski KA, Hematti P. Clinical applications of mesenchymal stem cells in soft tissue augmentation. Aesthetic Surgery Journal. 30(6):838-42, 2010. PMID: 2113458. PMCID: PMC4074905

30. Sloand E, Pfannes L, Ling C, Jasek M, Calado R, Tucker ZC, Feng X, Hematti P, Maciejewski J, Dunbar C, Barrett J, Young N. Graft-vs.-Host Disease: Role of Inflammation in the development of chromosomal abnormalities of keratinocytes. Biology of Blood Marrow Transplantation 2010 16(12):1665-73. PMID: 20659573. PMCID: PMC3437935

31. Orlando G, Hematti P, Stratta RJ, Burke GW, Cocco PD, Pisani F, Soker S, Wood K. Clinical operational tolerance after renal transplantation: current status and future challenges. Annals of Surgery. 252(6):915-28, 2010. PMID: 21107102

32. Lushaj EB, Anstadt E, Haworth R, Roennenburg D, Kim J, Hematti P, Kohmoto T. Mesenchymal stromal cells are present in the heart and promote growth of adult stem cell in vitro. Cytotherapy 13(4) 2011. PMID: 2109018

33. Hanson SE, King, SN, Kim J, Chen X, Thibeault SL, Hematti P. The effect of mesenchymal stromal cell – hyaluronic acid hydrogel constructs on immunophenotype of macrophages. Tissue Engineering Part A. 2011 Oct;17(19-20):2463-71. PMID: 21554192. PMCID: PMC3179618

34. Hematti P. Human Embryonic Stem Cell Derived Mesenchymal Stromal Cells. Transfusion 51(4S):138-144, 2011. PMCID: PMC3261503. PMCID: PMC3261503

35. Hematti P. Mesenchymal stromal cells and fibroblasts: a case of mistaken identity? Cytotherapy. 14(5):516-21, 2012. PMID: 22458957

36. Lushaj EB, Anstadt E, Haworth R, Roenneburg D, Kim J, Hematti P, Kohmoto T. Mesenchymal stromal cells are present in the heart and promote growth of adult stem cells in vitro. Cytotherapy. 2011 Apr;13(4):400-6. PMID: 21090918

37. Kim J, Denu R, Dollar B, Escalante L, Callander N, Asimakopoulos F, Hematti P. Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells. British Journal of Hematology. 2012 Aug;158(3):336-46. PMID: 22583117. PMCID: PMC3395762

38. Battiwalla M, Ellis K, Li P, Pavletic SZ, Akpek G, Hematti P, Klumpp TR, Maziarz RT, Savani B, Aljurf MD, Cairo MS, Drobyski W, George B, Hahn T, Khera N, Litzow MR, Loren AW, Saber W, Arora M, Urbano A, Cutler C, Flowers MED, Spellman SR. HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies. Biology of Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation. 2012 Aug; 18 (8):1302-8. PMID: 22414493. PMCID: PMC3580851

39. Kim J, Breunig M, Escalante L, Bhatia N, Denu RA, Dollar BA, Stein AP, Hanson SE, Naderi N, Radek J, Haughy D, Bloom DD, Poretr-Assadi FM, Hematti P. Biological and Immunomodulatory properties of mesenchymal stromal cells derived from human pancreatic islets. Cytotherapy, 2012 Sep;14(8):925-35. PMID: 22571381. PMCID: PMC3537170

40. Cantu DA, Hematti P, and Kao WJ. Cell encapsulating biomaterial regulates MSC differentiation and macrophage immunophenotype. Stem Cells Translational Medicine. 2012 Oct:1 (10) 740-749. PMID: 23197666. PMCID: PMC3659655

41. King SN, Hanson SE, Hematti P, Thibeault SL. Current applications of mesenchymal stem cells for tissue replacement in otolaryngology -- head and neck surgery. American Journal of Stem Cells. 2012;1(3):225-238. PMID: 23671810. PMCID: PMC3636735

42. Hematti P, Kim J, Stein AP, Kaufman D. Potential role of mesenchymal stromal cells in pancreatic islet transplantation. Transplantation Reviews. 2013 Jan;27(1):21-9. PMID: 23290684

43. Pulsipher MA, Chitphakdithai P, Logan BR, Shaw BE, Wingard JR, Lazarus HM, Waller EK, Seftel M, Stroncek DF, Lopez AM, Maharaj D, Hematti P, O’Donnel PV, Loren AW, Leitman SF, Goldstein SC, Levine JE, Navarro WH, Miller JP, Confer DL. Acute Toxicities of Unrelated Bone Marrow versus Peripheral Blood Stem Cell Donation: Results of a Prospective Trial from the NMDP. Blood. 2013 Jan 3;121(1):197-206. PMID: 23109243. PMCID: PMC3538330

44. Hanson SE, Kleinbeck KR, Cantu D, Kim J, Faucher LD, Kao WJ, Hematti P. Local delivery of allogeneic bone marrow and adipose tissue derived mesenchymal stromal cells for cutaneous wound healing in a porcine model. Journal of Tissue Engineering and Regenerative Medicine. 2013 Feb 18. PMID: 23418160. PMCID: PMC4050123

45. Hebron E, Hope C, Kim J, Jensen J, Flanagan C, Bhatia N, Maroulakou I, Miyamoto S, Callander N, Hematti P, Asimakopoulos F. MAP3K8 kinase regulates myeloma growth by cell-autonomous and non-autonomous mechanisms involving myeloma-associated monocytes/macrophages. British Journal of Hematology, 2013 Mar;160(6):779-84. PMID: 23252623. PMCID: PMC3594344

46. Castellone MD, Laatikainen LE, Laurila JP, Langella A, Hematti P, Soricelli A, Salvatore M, Laukkanen MO. Mesenchymal Stromal Cell Atrophy in Co-culture Increases Aggressiveness of Transformed cells. Stem Cells. 2013 Jun;31(6):1218-23. PMID: 23404893

47. Hanson SE, Kim J, Hematti P. Comparative analysis of adipose derived mesenchymal stem cells isolated from abdominal and breast tissue. Aesthetic Surgery Journal. 2013 Aug 1;33(6):888-98. PMID: 23908304

48. Kim J, Zanjani ED, Jeanblanc CM, Goodrich AD, Hematti P. Generation of CD34+ cells from human embryonic stem cells using a clinically applicable methodology and engraftment in the fetal sheep model. Experimental Hematology. 2013 Aug;41(8):749-758. PMID:23612043. PMCID: PMC3729638

49. Lockridge JL, Zhou Y, Becker YA, Ma S, Kenney SC, Hematti P, Capitini CM, Burlingham WJ, Fitzpatrick AG, Gumperz JE. Mice engrafted with human fetal thymic tissue and hematopoietic stem cells develop pathology resembling chronic GVHD. Biology of Blood and Marrow Transplantation. 2013 Sep;19(9):1310-22. PMID: 23806772. PMCID: PMC3755109

50. Asimakopoulos F, Kim J, Denu RA, Hope C, Jensen JL, Ollar SJ, EHebron E, Flanagan C, Callander N, Hematti P. Macrophages in multiple myeloma: emerging concepts and therapeutic implications. Leukemia and Lymphoma. 2013 Oct;54(10):2112-21. PMID: 23432691. PMCID: PMC3686978

51. Kim J, Escalante LE, Dollar BA, Hanson SE, Hematti P. Comparison of breast and abdominal adipose mesenchymal stem cells in support of proliferation of breast cancer cells. Cancer Investigation. 2013 Oct;31(8):550-4. PMID: 24020962. PMCID: PMC4136465

52. Xu K, Cantu DA, Fu Y, Kim J, Zheng X, Hematti P, Kao WJ. Thiol-ene Michaeltype formation of gelatin/poly(ethylene glycol) biomatrices for three dimensional mesenchymal stromal/stem cell administration to cutaneous wounds. Acta Biomaterialia. 2013 Nov;9(11):8802-14. PMID: 23811217. PMCID: PMC3791182

53. Sellers WE, Dumitriu B, Morgan MJ, Hughes VW, Wu CO, Raghavarchari N, Yang Y, Uchida N, Tisdale JF, An DS, Chen IS, Hematti P, Donahue RE, LaRochelle A, Young NS, Calado RT, Dunbar CE. No Impact of Lentiviral Transduction on Hematopoietic Stem/Progenitor Cell Telomere Length or Gene Expression in the Rhesus Macaque Model. Molecular Therapy. Molecular Therapy. 2014 Jan;22(1):52-8. PMID: 23863881. PMCID: PMC3978805

54. King SN, Hanson SE, Chen X, Kim J, Hematti P (co-corresponding author), Thibeault SL. Immunomodulatory and regenerative properties of mesenchymal stromal cells - hyaluronic acid hydrogel constructs. Journal of Biomedical Materials Research: Part A. 2014 Mar;102(3):890-902. PMID: 23564555

55. Wood D, Wesselschmidt R, Hematti P, Gee A, Rooney C, Silberstein L, Armant M, Couture L, Wagner J, McKenna D. Jr., Hei D, Heath Mondoro T, Welniak L, Lindblad R. An Update from the United States National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) Program: A Decade of Cell Therapy. Clinical and Translational science. 2014 Apr;7(2):93-9. PMID: 24655892

56. Hope C, Ollar SJ, Heninger E, Hebron E, Jensen J, Kim J, Maroulakou I, Miyamoto S, Leith C, Yang DT, Callander N, Hematti P, Chesi M, Bergsagel L, Asimakopoulos F. TPL2 kinase regulates the inflammatory milieu of the myeloma niche. Blood. 2014 May 22;123(21):3305-15. PMID: 24723682

57. Viswanathan S, Keating A, Deans R, Hematti P, Prockop D, Stroncek D, Stacey G, Weiss D, Mason C, Rao M. Soliciting Strategies for Developing Cell-Based Reference Materials to Advance MSC Research and Clinical Translation. Stem Cells Development. 2014 June; 23(11):1157-67. PMID: 24422625. PMCID: PMC4027980

58. Goodrich AD, Hematti P. Mesenchymal stem cell therapies: the quest for fine-tuning. Experimental Dermatology. 2014 July; 23, 632-3. PMID: 24806552

59. Hanley PJ, Mei Z, Durett AG, Cabreira-Harrison MG, Klis M, Li W, Zhao Y, Yang B, Parsha K, Mir O, Vahidy F, Bloom D, Rice RB, Hematti P, Savitz SI, Gee AP. Efficient Manufacturing of Therapeutic Mesenchymal Stromal Cells Using the Quantum Cell Expansion System. Cytotherapy. 2014 Aug;16 (8):1048-58. PMID: 24726657

60. Hanson SE, D'Souza RN, Hematti P. Biomaterial - Mesenchymal Stem Cell Constructs for Immunomodulation in Composite Tissue Engineering. Tissue Engineering Part A. 2014 Aug;20(15-16):2162-68. PMID: 25140989

61. Goodrich DA, Varain NM, Jeanblanc CM, Colon DM, Kim J, Zanjani ED, Hematti P. Influence of a dual-injection regimen, Plerixafor, and CXCR4 on in-utero hematopoietic stem cell transplantation and engraftment using the sheep model. Cytotherapy. 2014 Sep;16(9):1280-93. PMID: 25108653

62. Callander N1, Markovina S, Eickhoff J, Hutson P, Campbell T, Hematti P, Go R, Hegeman R, Longo W, Williams E, Asimakopoulos F, Miyamoto S. Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network. Cancer Chemotherapy and Pharmacology. 2014 Oct;74(4):875-82. PMID: 25168296. PMCID: PMC4175433

63. Nelson AM, Coe CL, Juckett MB, Rumble ME, Rathouz P, Hematti P, Costanzo ES. Sleep quality following hematopoietic stem cell transplantation: longitudinal trajectories and biobehavioral correlates. Bone Marrow Transplantation. 2014 Nov;49(11):1405-11. PMID: 25133898

64. Raval AN, Schmuck E Tefera G, Leitzke C, Vander Ark C, Hei D, Centanni JM, de Silva R, Koch J, Chappell R, Hematti P. Bilateral Administration of Autologous CD133+ Cells in Ambulatory Patients with Refractory Critical Limb Ischemia: Lessons Learned from a Pilot Randomized, Double blind, Placebo-controlled Trial. Cytotherapy. 2014 Dec;16(12):1720-32. PMID: 25239491

65. Cuiffo BG, Campagne A, Bell GW, Lembo A, Orso F, Lien E, Bhasin MK, Raimo M, Hanson SE, Marusyk A, El-Ashry D, Hematti P, Polyak K, Mechta-Grigoriou F, Mariani O, Volinia S, Vincent-Salomon A, Taverna D, Karnoub AE. MSC-Regulated MicroRNAs Converge on the Speech Gene FOXP2 and Regulate Breast Cancer Metastasis. Cell Stem Cell. 2014 Dec 4;15(6):762-774. PMID: 25515522

66. Hsu JW, Wingard J, Logan B, Chitphakdithai P, Akpek G, Anderlini P, Artz A, Bredeson C, Goldstein S, Hale G, Hematti P, Joshi S, Kamble RT, Lazarus HM, O'Donnell PV, Pulsipher MA, Savani B, Schears RM, Shaw BE, Confer DL. Race and ethnicity influences collection of G-CSF mobilized peripheral blood progenitor cells from unrelated donors, a CIBMTR analysis. Biology of Blood and Bone Marrow Transplantation. 2015 Jan;21(1):165-71. PMID: 25316111

67. Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, Urbano-Ispizua A, Cutler CS, Bacigalupo AA, Battiwalla M, Flowers ME, Juckett MB, Lee SJ, Loren AW, Klumpp TR, Prockup SE, Ringdén OT, Savani BN, Socié G, Schultz KR, Spitzer T, Teshima T, Bredeson CN, Jacobsohn DA, Hayashi RJ, Drobyski WR, Frangoul HA, Akpek G, Ho VT, Lewis VA, Gale RP, Koreth J, Chao NJ, Aljurf MD, Cooper BW, Laughlin MJ, Hsu JW, Hematti P, Verdonck LF, Solh MM, Norkin M, Reddy V, Martino R, Gadalla S, Goldberg JD, McCarthy PL, Pérez-Simón JA, Khera N, Lewis ID, Atsuta Y, Olsson RF, Saber W, Waller EK, Blaise D, Pidala JA, Martin PJ, Satwani P, Bornhäuser M, Inamoto Y, Weisdorf DJ, Horowitz MM, Pavletic SZ; Graft-vs-Host Disease Working Committee of the CIBMTR. Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation - A Report from CIBMTR. Biology of Blood and Bone Marrow Transplantation. 2015 Feb;21(2):266-74. PMID: 25445023

68. Bloom DD, Centanni JM, Bhatia N, Emler CA, Drier D, Leverson GE, McKenna Jr. DH, Gee AP, Lindblad R, Hei DJ, Hematti P. A Reproducible Immunopotency Assay to Measure Mesenchymal Stromal Cell Mediated T Cell Suppression. Cytotherapy. 2015 Feb;17(2):140-51. PMID: 25455739

69. Lindblad R, Ibenana L, Gee A, Rooney C, Wagner J, McKenna D, Hei H, Hematti P, Couture L, Silberstein L, Armant M, Welniak L, Mondoro TH. Cell Therapy Product Administration and Safety: Ten Years of Experience from the Production Assistance for Cellular Therapies (PACT) Program. Transfusion 2015 Mar;55(3):674-9. PMID: 25315143

70. Guerra A, Cantu DA, Rose WE, Hematti P, Kao WJ. Staphyloccous aureus evades the immunomodulatory function of biomaterial-encapsulated mesenchymal stromal/stem cells and blood-derived leukocytes. AAPS Journal. 2015 May;17(3):620-30. PMID: 25716147

71. Jensen JL, Rakhmilevich A, Heninger E, Broman AT, Hope C, Phan F, Miyamoto S, Maroulakou I, Callander N, Hematti P, Chesi M, Bergsagel PL, Sondel PM, Asimakopoulos F. Tumoricidal effects of macrophage-activating immunotherapy in a murine model of relapsed/refractory multiple myeloma. Cancer Immunology Research. Cancer Immunol Res. 2015 Aug;3(8):881-90. PMID: 25941352

72. Gupta A, Place M, Goldstein S, Sarkar D, Zhou S, Potamousis K, Kim J, Flanagand C, Li Y, Newton MA, Callander NS, Hematti P, Bresnick EH, Ma J, Asimakopoulos F, Schwartz DC. Molecule Analysis Reveals Widespread Structural Variation and Clonal Evolution in Multiple Myeloma. Proceeding of the National Academy of Sciences USA. 2015 Jun 23;112(25):7689-94. PMID: 26056298

73. Shaw BE, Logan BR, Kiefer DM, Chitphakdithai P, Pedersen TL, Abdel-Azim H, Abidi MH, Akpek G, Diaz MA, Artz AS, Dandoy C, Gajewski JL, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Majhail NS, O’Donnell PV, Olsson RF, Savani BN, Schears RM, Stroncek DF, Switzer GE, Williams EP, Wingard JR, Wirk BM, Confer DL, Pulsipher MA. An Analysis of the Effect of Race, Socioeconomic Status and Center Size on Unrelated NMDP Donor Outcomes: Donor Toxicities are More Common at Low Volume Bone Marrow Collection Centers. Biology of Blood and Marrow Transplantation. 2015 Oct;21(10):1830-8. PMID: 26116089

74. Schmuck EG, Koch JM, Hacker TA, Hatt CR, Tomkowiak MT, Vigen KK, Hendren N, Zhao Y, Li Z, Centanni JM. Hei DJ, Schwahn D, Kim J, Hematti P, Raval AN. Intravenous Infusion Followed by Targeted Transendocardial Administration of Allogeneic Mesenchymal Stem Cells Improves Contractility Reserve, but Does Not Affect Infarct Size or Ejection Fraction in a Swine Myocardial Infarction Model. Journal of Cardiovascular Translational Medicine. 2015 Oct;8(7):438-48. PMID: 26374144

75. Anthias C, Shaw BE, Kiefer DM, Liesveld JL, Yared J, Kamble RT, D'Souza A, Hematti P, Seftel M, Norkin M, DeFilipp Z, Kasow KA, Abidi MH, Savani BN, Shah N, Anderlini P, Diaz MA, Malone AK, Halter JP, Lazarus HM, Logan BR, Switzer GE, Pulsipher MA, Confer DL, O'Donnell PV. Significant improvements in the practice patterns of adult related donor care in US transplant centers. Biology of Blood and Marrow Transplantation. 2016 Mar;22(3):520-7. PMID: 26597080

76. Yu W, Denu RA, Krautkramer KA, Grindle KM, Yang DT, Asimakopoulos F, Hematti P, Denu JM. Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies. Journal of Biological Chemistry. Feb 12;291(7):3268-79. PMID: 26631723

77. Braun R, Koch JM, Hacker TA, Pegelow D, Kim J, Raval AN, Schmuck EG, Schwahn DJ, Hei DJ, Centanni JM, Eldridge M, Hematti P. Cardiopulmonary and histological characterization of an acute rat lung injury model demonstrating safety of mesenchymal stromal cell infusion. Cytotherapy. 2016 Apr;18(4):536-45. PMID: 26971682

78. Hematti P. Characterization of mesenchymal stromal cells: potency assay development. Transfusion. 2016 Apr;56(4):32S-5S. PMID: 27079322

79. Denu RA, Nemcek S, Bloom DD, Goodrich AD, Kim J, Mosher DF, Hematti P. Fibroblasts and Mesenchymal Stromal Cells are Phenotypically Indistinguishable. Acta Haematologica, 2016. Acta Haematologica. 2016;136(2):85-97. PMID: 27188909

80. Denu R, Hematti P. Effects of Oxidative Stress on Mesenchymal Stem Cell Biology". Oxidative Medicine and Cellular, 2106. PMID: 27413419

81. Hope C, Foulcer S, Jagodinsky J, Chen SX, Jensen JL, Patel S, Leith C, Maroulakou I, Callander N, Miyamoto S, Hematti P, Apte SS, Asimakopoulos F. Immunoregulatory roles of versican proteolysis in the myeloma microenvironment, Blood, 2016 Aug 4;128(5):680-5. PMID: 27259980

82. Azari AA, Karadag R, Kanavi MR, Nehls S, Barney N, Kim K, Longo W, Hematti P, Juckett M. Safety and efficacy of autologous serum eye drop for treatment of dry eyes in graft-versus-host disease. Cutaneous and Ocular Toxicology. 2017 Jun;36(2):152-156. PMID: 27380960

83. Muir P, Hans EC, Racette M, Volstad N, Sample SJ, Heaton C, Holzman G, Schaefer SL, Bloom D, Bleedorn JA, Hao Z, Amene E, Suresh M, Hematti P. Autologous bone marrow-derived mesenchymal stem cells elicit an anti-inflammatory response in dogs with cruciate ligament rupture. PLosOne. 2016 Aug 30;11(8): e0159095. PMID: 27575050

84. Haynes LD, Coonen J, Post J, Brunner K, Bloom D, Hematti P, Kaufman DB. Collection of Hematopoietic CD34 Stem Cells in Rhesus Macaques using Spectra Optia. Journal of Clinical Apheresis. 2017 Oct;32(5):288-294. PMID: 27578423

85. Schmuck EG, Koch JM, Centanni JM, Hacker TA, Braun RK, Eldridge M, Hei DJ, Hematti P, Raval AN. Biodistribution and Clearance of Human Mesenchymal Stem Cells by Quantitative Three-dimensional Cryo-imaging Following Intravenous Infusion in a Rat Lung Injury Model. Stem Cells Translational Medicine, 2016 Dec;5(12):1668-1675. PMID: 27460855

86. Guerra DA, Rose WE, Hematti P, John Kao W. Minocycline enhances the mesenchymal stromal/stem cell pro-healing phenotype in triple antimicrobial-loaded hydrogels. Acta Biomaterialia. 2017 Jan 6. PMID: 28069512

87. Brunstein C, Zhang MJ, Barker J, Martin AS, Bashey A, de Lima M, Dehn J, Hematti P, Perales MA, Rocha V, Territo M, Weisdorf D, Eapen M. The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia. Haematologica. 2017 May;102(5):941-947. PMID: 28126967

88. Parascandolo A, Rappa F, Cappello F, Kim J, Cantu DA, Chen H, Mazzoccoli G, Hematti P, Domenica Castellone M, Salvatore M, Laukkanen MO. Extracellular Superoxide Dismutase Expression in Papillary Thyroid Cancer Mesenchymal Stem/Stromal Cells Modulates Cancer Cell Growth and Migration. Scientific Reports. 2017 Feb 20:7:41416. PMID: 28216675

89. McMannes JL, Hershberger J, Parker DM, De Reys S, Loos T, Hematti P. Customizing anticoagulation strategies during leukapheresis to limit citrate exposure. ISBT (International Society of Blood Transfusion) Science Series. 2017 May 12:2, 297-306

90. Bouchlaka MN, Moffitt AB, Kim J, Kink JA, Bloom D, Love C, Dave S, Hematti P, Capitini CM. Human Mesenchymal Stem Cell-Educated Macrophages are a Distinct High IL-6 Producing Subset That Confer Protection in Graft-Versus-Host-Disease and Radiation Injury Models.Accepted for Publication in: Biology of Blood and Marrow Transplantation. Biolology of Blood and Marrow Transplantation. Jun;23(6):897-905. PMID: 28257800

91. Khoury HJ, Wang T, Hemmer MT, Couriel D, Alousi A, Cutler C, Aljurf M, Antin JH, Ayas M, Battiwalla M, Cahn JY, Cairo M, Chen YB, Gale RP, Hashmi S, Hayashi RJ, Jagasia M, Juckett M, Kamble RT, Kharfan-Dabaja M, Litzow M, Majhail N, Miller A, Nishihori T, Qayed M, Schoemans H, Schouten HC, Socié G, Storek J, Verdonck L, Vij R, Wood WA, Yu L, Martino R, Carabasi M, Dandoy C, Gergis U, Hematti P, Solh M, Jamani K, Lehmann L, Savani B, Schultz KR, Wirk BM, Spellman S, Arora M, Pidala J. Improved Survival after Acute Graft vs. Host Disease Diagnosis in the Modern Era. Haematologica. 2017 May;102(5):958-966. PMID: 28302712

92. Liu S, de Castro LF, Jin P, Civini S, Ren J, Reems JA, Cancelas J, Nayak R, Shaw G, O'Brien T, McKenna DH, Armant M, Silberstein L, Gee AP, Hei DJ, Hematti P, Kuznetsov SA, Robey PG, Stroncek DF. Manufacturing Differences Affect Human Bone Marrow Stromal Cell Characteristics and Function: Comparison of Production Methods and Products from Multiple Centers. Sci Rep. 2017 Apr 27;7:46731. PMID: 28447618

93. Vrooman LM, Millard HR, Brazauskas R, Majhail NS, Battiwalla M, Flowers ME, Savani BN, Akpek G, Aljurf M, Bajwa R, Baker KS, Beitinjaneh A, Bitan M, Buchbinder D, Chow E, Dandoy C, Dietz AC, Diller L, Gale RP, Hashmi SK, Hayashi RJ, Hematti P, Kamble RT, Kasow KA, Kletzel M, Lazarus HM, Malone AK, Marks DI, O'Brien TA, Olsson RF, Ringden O, Seo S, Steinberg A, C Yu L, Warwick A, Shaw B, Duncan C. Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less Than Three Years of Age. Biology of Blood and Marrow Transplantation. 2017 Aug;23(8):1327-1334. PMID: 28461213

94. Guerra AD, Rose WE, Hematti P, Kao WJ. Minocycline modulates NFκB phosphorylation and enhances antimicrobial activity against Staphylococcus aureus in mesenchymal stromal/stem cells. Stem Cell Res & Therapy. 2017 Jul 21;8(1):171. PMID: 28732530

95. Hope C, Emmerich PB, Papadas A, Pagenkopf A, Matkowskyj KA, Van De Hey DR, Payne SN, Clipson L, Callander NS, Hematti P, Miyamoto S, Johnson MG, Deming DA, Asimakopoulos F. Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer. Journal of Immunology. 2017 Sep 1;199(5):1933-1941. PMID: 28754680

96. Piscopo NJ, Mueller KP, Das A, Hematti P, Murphy WL, Palecek SP, Capitini CM, Saha K. Bioengineering solutions for manufacturing challenges in CAR T cells. Biotechnol J. 2017 Aug 25. doi: 10.1002/biot.201700095. [Epub ahead of print] PMID: 28840981

97. Stroncek DF, Shaw BE, Logan BR, Kiefer DM, Savani BN, Anderlini P, Bredeson CN, Hematti P, Ganguly S, Diaz MA, Abdel-Azim H, Ahmed I, Maharaj D, Seftel M, Beitinjaneh A, Seo S, Yared JA, Halter J, O'Donnell PV, Hale GA, Defilipp Z, Lazarus H, Liesveld JL, Zhou Z, Munshi P, Olsson RF, Kasow KA, Szer J, Switzer GE, Chitphakdithai P, Shah N, Confer DL, Pulsipher MA. Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields are Less. Biolology of Blood and Marrow Transplantation. 2018 Jan;24(1):175-184. PMID: 28958894

98. Eslani M, Putra I, Shen X, Hamouie J, Afsharkhamseh N, Besharat S, Rosenblatt MI, Dana R, Hematti P (co-corresponding author), Djalilian AR. Corneal Mesenchymal Stromal Cells Are Directly Antiangiogenic via PEDF and sFLT-1. Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5507-5517. PMID: 29075761

99. Qayed M, Wang T, Hemmer MT, Spellman S, Arora M, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Aljuf M, Ayas M, Bitan M, Cairo M, Choi SW, Dandoy C, Delgado D, Gale RP, Hale G, Frangoul H, Kamble RT, Kharfan-Dabaja M, Lehman L, Levine J, MacMillan M, Marks DI, Nishihori T, Olsson RF, Hematti P, Ringden O, Saad A, Satwani P, Savani BN, Schultz KR, Seo S, Shenoy S, Waller EK, Yu L, Horowitz MM, Horan J. Influence of Age on Acute and Chronic GVHD in Children Receiving HLA-Identical Sibling BMT for Acute Leukemia: Implications for Prophylaxis. Biology of Blood and Marrow Transplantation. 2018 Mar;24(3):521-528. PMID: 29155316

100. Huynh M, Pak C, Markovina S, Callander NS, Chng KS, Wuerzberger-Davis SM, Bakshi DD, Kink JA, Hematti P, Hope C, Asimakopoulos F, Rui L, Miyamoto S. Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-κB activity and increases drug resistance in multiple myeloma. J Biol Chem. 2018 Feb 16;293(7):2452-2465. PMID: 29279332

101. Bloom DD, Reshetylo S, Nytes C, Goodsett CT, Hematti P. Blockade of BAFF Receptor BR3 on T Cells Enhances Their Activation and Cytotoxicity. J Immunother. 2018 Jun;41(5):213-223. PMID: 29309290

102. Eslani M, Putra I, Shen X, Hamouie J, Tadepalli A, Anwar KN, Kink JA, Ghassemi S, Agnihotri G, Reshetylo S, Mashaghi A, Dana R, Hematti P (co-corresponding author), Djalilian AR. Cornea Derived MSCs Therapeutically Modulate Macrophage Immunophenotype and Angiogenic Function. Stem Cells. 2018 May;36(5):775-784. PMID: 29341332

103. Turcotte LM, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Ahmed I, Beitinjaneh A, Buchbinder D, Byrne M, Callander N, Chao N, Choi SW, DeFilipp Z, Gadalla SM, Gale RP, Gergis U, Hashmi S, Hematti P, Holmberg L, Inamoto Y, Kamble RT, Lehmann L, MacMillan MA, McIver Z, Nishihori T, Norkin M, O'Brien T, Olsson RF, Reshef R, Saad A, Savani BN, Schouten HC, Seo S, Solh M, Verdonck L, Vij R, Wirk B, Yared J, Horowitz MM, Knight JM, Verneris MR. Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation. Bone Marrow Transplant. 2018 Jul;53(7):932-937. PMID: 29382954

104. Radivoyevitch T, Dean RM, Shaw BE, Brazauskas R, Tecca HR, Molenaar RJ, Battiwalla M, Savani BN, Flowers MED, Cooke KR, Hamilton BK, Kalaycio M, Maciejewski JP, Ahmed I, Akpek G, Bajel A, Buchbinder D, Cahn JY, D'Souza A, Daly A, DeFilipp Z, Ganguly S, Hamadani M, Hayashi RJ, Hematti P, Inamoto Y, Khera N, Kindwall-Keller T, Landau H, Lazarus H, Majhail NS, Marks DI, Olsson RF, Seo S, Steinberg A, William BM, Wirk B, Yared JA, Aljurf M, Abidi MH, Allewelt H, Beitinjaneh A, Cook R, Cornell RF, Fay JW, Hale G, Chakrabarty JH, Jodele S, Kasow KA, Mahindra A, Malone AK, Popat U, Rizzo JD, Schouten HC, Warwick AB, Wood WA, Sekeres MA, Litzow MR, Gale RP, Hashmi SK. Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma. Leuk Res. 2018 Nov;74:130-136. PMID: 30055822

105. Braun RK, Chetty C, Balasubramaniam V, Centanni R, Haraldsdottir K, Hematti P, Eldridge MW. Intraperitoneal injection of MSC-derived exosomes prevent experimental bronchopulmonary dysplasia. Biochem Biophys Res Commun. 2018 Sep 18;503(4):2653-2658. PMID: 30093115

106. GATA/Heme Multi-omics Reveals a Trace Metal-Dependent Cellular Differentiation Mechanism. Tanimura N, Liao R, Wilson GM, Dent MR, Cao M, Burstyn JN, Hematti P, Liu X, Zhang Y, Zheng Y, Keles S, Xu J, Coon JJ, Bresnick EH. Dev Cell. 2018 Sep 10;46(5):581-594. PMID: 30122630

107. Chhabra S, Liu Y, Hemmer MT, Costa L, Pidala JA, Couriel DR, Alousi AM, Majhail NS, Stuart RK, Kim D, Ringden O, Urbano-Ispizua A, Saad A, Savani BN, Cooper B, Marks DI, Socie G, Schouten HC, Schoemans H, Abdel-Azim H, Yared J, Cahn JY, Wagner J, Antin JH, Verdonck LF, Lehmann L, Aljurf MD, MacMillan ML, Litzow MR, Solh MM, Qayed M, Hematti P, Kamble RT, Vij R, Hayashi RJ, Gale RP, Martino R, Seo S, Hashmi SK, Nishihori T, Teshima T, Gergis U, Inamoto Y, Spellman SR, Arora M, Hamilton BK. Comparative analysis of calcineurin-inhibitor-based methotrexate and mycophenolate mofetil-containing regimens for prevention of Graft-versus-Host Disease after reduced intensity conditioning allogeneic transplantation. Biology of Blood and Marrow Transplantation. 2019 Jan;25(1):73-85PMID: 30153491

108. Sahasrabudhe K, Otto M, Hematti P, Kenkre V. TCR αβ+/CD19+ cell depletion in haploidentical hematopoietic allogeneic stem cell transplantation: a review of current data. Leuk Lymphoma. 2019 Mar;60(3):598-60. PMID: 30187806

109. Norkin M, Shaw BE, Brazauskas R, Tecca HR, Leather HL, Gea-Banacloche J, Kamble R, DeFilipp Z, Jacobsohn DA, Ringden O, Inamoto Y, Kasow K, Buchbinder D, Shaw P, Hematti P, Schears R, Badawy SM, Lazarus HM, Bhatt N, Horn B, Chhabra S, Page K, Hamilton B, Hildebrandt GC, Yared JA, Agrawal V, Beitinjaneh A, Majhail N, Kindwall-Keller T, Olsson RF, Schoemans H, Gale RP, Ganguly S, Ahmed I, Schouten HC, Liesveld J, Khera N, Steinberg A, Shah AJ, Solh M, Marks DI, Rybka W, Aljurf M, Dietz AC, Gergis U, George B, Seo S, Flowers MED, Battiwalla M, Savani BN, Riches ML, Wingard JR. Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplant. Biology of Blood and Marrow Transplantation. 2019 Feb;25(2):362-368. PMID: 30287390

110. Samaeekia R, Rabiee B, Putra I, Shen X, Park YJ, Hematti P, Eslani M, Djalilian AR. Effect of Human Corneal Mesenchymal Stromal Cell-derived Exosomes on Corneal Epithelial Wound Healing. Invest Ophthalmolology and Visual Science. 2018 Oct 1;59(12):5194-5200. PMID: 30372747

111. Brunstein CG, Pasquini MC, Kim S, Fei M, Adekola K, Ahmed I, Aljurf M, Agrawal V, Auletta JJ, Battiwalla M, Bejanyan N, Bubalo J, Cerny J, Chee L, Ciurea SO, Freytes C, Gadalla SM, Gale RP, Ganguly S, Hashmi SK, Hematti P, Hildebrandt G, Holmberg LA, Lahoud OB, Landau H, Lazarus HM, de Lima M, Mathews V, Maziarz R, Nishihori T, Norkin M, Olsson R, Reshef R, Rotz S, Savani B, Schouten HC, Seo S, Wirk BM, Yared J, Mineishi S, Rogosheske J, Perales MA. Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell transplantation. Biol Blood Marrow Transplant. 2019 Mar;25(3):480-487. PMID: 30423481

112. Inamoto Y, Petriček I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rovó A, Schears R, Shah A, Agrawal V, Ahmed A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Law J, Lee C, Nathan S, Penack O, Pingali R, Prasad P, Pulanic D, Rotz S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers ME, Shaw BE, Valdés-Sanz N. Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Biol Blood Marrow Transplant. 2019 May;25(5):e145-e154. PMID: 30521975

113. Inamoto Y, Petriček I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rovó A, Schears R, Shah A, Agrawal V, Ahmed A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Law J, Lee C, Nathan S, Penack O, Pingali R, Prasad P, Pulanic D, Rotz S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Valdés-Sanz N. Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Bone Marrow Transplant. 2019 May;54(5):648-661. Review. PMID: 30531955

114. Prokopishyn NL, Logan BR, Kiefer DM, Sees JA, Chitphakdithai P, Ahmed IA, Anderlini PN, Beitinjaneh AM, Bredeson C, Cerny J, Chhabra S, Daly A, Diaz MA, Farhadfar N, Frangoul HA, Ganguly S, Gastineau DA, Gergis U, Hale GA, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Murthy HS, Norkin M, Olsson RF, Papari M, Savani BN, Szer J, Waller EK, Wirk B, Yared JA, Pulsipher MA, Shah NN, Switzer GE, O'Donnell PV, Confer DL, Shaw BE. The concentration of total nucleated cells in harvested bone marrow for transplantation has decreased over time. Biol Blood Marrow Transplant. 2019 Jul;25(7):1325-1330. PMID: 30716454

115. Chamberlain CS, Clements AB, Kink JA, Choi U, Baer GS, Halanski MA, Hematti P (co-corresponding author), Vanderby R. Stem Cells. 2019 Feb 5. Extracellular vesicle-educated macrophages promote early Achilles tendon healing. Stem Cells. 2019 May;37(5):652-662. PMID: 30720911

116. Dhakal B, Pagenkopf A, Umair Mushtaq M, Cunningham AM, Flietner E, Morrow Z, Papadas A, Hope C, Leith C, Hematti P, Hari P, Callander NS, Asimakopoulos F. Versican proteolysis predicts immune effector infiltration and post-transplant survival in myeloma. Leuk Lymphoma. 2019 Mar 8:1-5. [Epub ahead of print]. PMID: 30845856

117. Parikh SH, Satwani P, Ahn KW, Sahr NA, Fretham C, Abraham AA, Agrawal V, Auletta JJ, Abdel-Azim H, Copelan E, Diaz MA, Dvorak CC, Frangoul HA, Freytes CO, Gadalla SM, Gale RP, George B, Gergis U, Hashmi S, Hematti P, Hildebrandt GC, Keating AK, Lazarus HM, Myers KC, Olsson RF, Prestidge T, Rotz SJ, Savani BN, Shereck EB, Williams KM, Wirk B, Pasquini MC, Loren AW. Survival Trends in Infants Undergoing Allogeneic Hematopoietic Cell Transplant. JAMA Pediatr. 2019 Mar. [Epub ahead of print] PMID: 30882883

118. Mehta RS, Holtan SG, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Alousi AM, Pidala J, Abdel-Azim H, Ahmed I, Aljurf M, Askar M, Auletta JJ, Bhatt V, Bredeson C, Chhabra S, Gadalla S, Gajewski J, Gale RP, Gergis U, Hematti P, Hildebrandt GC, Inamoto Y, Kitko C, Khandelwal P, MacMillan ML, Majhail N, Marks DI, Mehta P, Nishihori T, Olsson RF, Pawarode A, Diaz MA, Prestidge T, Qayed M, Rangarajan H, Ringden O, Saad A, Savani BN, Seo S, Shah A, Shah N, Schultz KR, Solh M, Spitzer T, Szer J, Teshima T, Verdonck LF, Williams KM, Wirk B, Wagner J, Yared JA, Weisdorf DJ. GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia. Blood Adv. 2019 May 14;3(9):1441-1449. PMID: 31053571

119. Saad A, Lamb L, Wang T, Hemmer MT, Spellman S, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Agrawal V, Aljurf M, Beitinjaneh AM, Bhatt VR, Buchbinder D, Byrne M, Cahn JY, Cairo M, Castillo P, Chhabra S, Diaz MA, Farhan S, Floisand Y, Frangoul HA, Gadalla SM, Gajewski J, Gale RP, Gandhi M, Gergis U, Hamilton BK, Hematti P, Hildebrandt GC, Kamble RT, Kanate AS, Khandelwal P, Lazaryn A, MacMillan M, Marks DI, Martino R, Mehta PA, Nishihori T, Olsson RF, Patel SS, Qayed M, Rangarajan HG, Reshef R, Ringden O, Savani BN, Schouten HC, Schultz KR, Seo S, Shaffer BC, Solh M, Teshima T, Urbano-Ispizua A, Verdonck LF, Vij R, Waller EK, William B, Wirk B, Yared JA, Yu LC, Arora M, Hashmi S. Impact of T-cell dose on the outcome of T-cell replete HLA matched allogeneic peripheral blood stem cell transplantation. Biol Blood Marrow Transplant. 2019 Sep;25(9):1875-1883. PMID: 31085303

120. Chinnadurai R, Rajakumar A, Schneider AJ, Bushman WA, Hematti P, Galipeau J. Potency analysis of Mesenchymal Stromal Cells using a phospho-STAT matrix loop analytical approach. Stem Cells. 2019 Aug;37(8):1119-1125. PMID: 31108008

121. Hamilton BK, Liu Y, Hemmer MT, Majhail N, Ringden O, Kim D, Costa L, Stuart R, Alousi A, Pidala JA, Couriel DR, Aljurf M, Antin JH, Bredeson C, Cahn JY, Cairo M, Choi SW, Dandoy C, Gale RP, Gergis U, Hematti P, Inamoto Y, Kamble RT, MacMillan M, Marks DI, Nemecek E, Nishihori T, Saad A, Savani BN, Schriber J, Seo S, Socié G, Teshima T, Verdonck LF, Waller EK, Wirk M, Spellman SR, Arora M, Chhabra S. Inferior Outcomes with Cyclosporine and Mycophenolate mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2019 Sep;25(9):1744-1755. PMID: 31158502

122. Lung DK, Warrick JW, Hematti P, Callander NS, Mark CJ, Miyamoto S, Alarid ET. Bone marrow stromal cells transcriptionally repress ESR1 but cannot overcome constitutive ESR1 mutant activity. Endocrinology. 2019 Oct 1;160(10):2427-2440. PMID: 31504407

123. Solomon SR, St Martin A, Shah NN, Fatobene G, Al Malki MM, Ballen KK, Bashey A, Bejanyan N, Bolaños Meade J, Brunstein CG, DeFilipp Z, Champlin RE, Fuchs EJ, Hamadani M, Hematti P, Kanakry CG, McGuirk JP, McNiece IK, Ciurea SO, Pasquini MC, Rocha V, Romee R, Patel SS, Vasu S, Waller EK, Wingard JR, Zhang MJ, Eapen M. Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy. Blood Adv. 2019 Oct 8;3(19):2836-2844. PMID: 31582392.

124. Kink JA, Forsberg MH, Reshetylo S, Besharat S, Childs CJ, Pederson JD, Gendron-Fitzpatrick A, Graham M, Bates PD, Schmuck EG, Raval A, Hematti P, Capitini CM. Macrophages Educated with Exosomes from Primed Mesenchymal Stem Cells Treat Acute Radiation Syndrome by Promoting Hematopoietic Recovery. Biol Blood Marrow Transplant. 2019 Nov;25(11):2124-2133. PMID: 31394269

125. Kaufman DB, Hematti P, Golden RN. Immunosuppression-Free Kidney Transplantation: Advancing New Treatments by Building on Our Past Foundations. WMJ. 2019 Oct;118(3):146-147. PMID: 31682753

126. Sabloff M, Chhabra S, Wang T, Fretham C, Kekre N, Abraham A, Adekola K, Auletta JJ, Barker C, Beitinjaneh AM, Bredeson C, Cahn JY, Diaz MA, Freytes C, Gale RP, Ganguly S, Gergis U, Guinan E, Hamilton B, Hashmi S, Hematti P, Hildebrandt G, Holmberg L, Hong S, Lazarus HM, Martino R, Muffly L, Nishihori T, Perales MA, Yared J, Mineishi S, Stadtmauer EA, Pasquini MC, Loren AW. Comparison of high doses of total body irradiation in myeloablative conditioning prior to hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2019 Dec;25(12):2398-2407. PMID: 31473319

127. Fontana G, Martin HL, Lee JS, Schill K, Hematti P, Murphy WL. Mineral-Coated Microparticles Enhance mRNA-Based Transfection of Human Bone Marrow Cells. Mol Ther Nucleic Acids. 2019 Dec 6;18:455-464. PMID: 31655263

128. Zinter MS, Logan BR, Fretham C, Sapru A, Abraham A, Aljurf MD, Arnold SD, Artz A, Auletta JJ, Chhabra S, Copelan E, Duncan C, Gale RP, Guinan E, Hematti P, Keating AK, Marks DI, Olsson R, Savani BN, Ustun C, Williams KM, Pasquini MC, Dvorak CC. Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries. Biol Blood Marrow Transplant. 2020 Feb;26(2):333-342. PMID: 31563573

129. Dandoy CE, Kim S, Chen M, Ahn KW, Ardura MI, Brown V, Chhabra S, Diaz MA, Dvorak C, Farhadfar N, Flagg A, Ganguly S, Hale GA, Hashmi SK, Hematti P, Martino R, Nishihori T, Nusrat R, Olsson RF, Rotz SJ, Sung AD, Perales MA, Lindemans CA, Komanduri KV, Riches ML. Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant. JAMA Netw Open. 2020 Jan 3;3(1):e1918668. doi: 10.1001/jamanetworkopen.2019.18668. PMID: 31913492

130. Hsu JW, Shaw BE, Kim S, Logan BR, Sees JA, Confer DL, Pulsipher MA, Shah N, Switzer GE, Abidi MH, Ahmed IA, Anderlini PN, Bredseon C, Chhabra S, Dandoy CE, Diaz MA, Farhadfar N, Ganguly S, Gergis U, Hale GA, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Murthy HS, Olsson RF, Savani BN, Schears R, Seo S, Solh M, Spitzer T, Steinberg A, Sugure M, Warkentin P, Wingard JR. Collection of Peripheral Blood Progenitor Cells in One Day is Associated with Decreased Donor Toxicity compared to Two Days in Unrelated Donors. Biol Blood Marrow Transplant. 2020 Jun;26(6):1210-1217. PMID: 32088366

131. Farhadfar N, Hsu JW, Logan BR, Sees JA, Chitphakdithai P, Sugrue MW, Abdel-Azim H, Anderlini PN, Bredeson C, Chhabra S, Diaz MA, Ganguly S, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Lynch DK, Murthy HS, Olsson RF, Papari M, Przepiorka D, Savani BN, Schears R, Seo S, Solh MM, Spitzer T, Yared JA, Pulsipher MA, Shah NN, Switzer GE, Confer DL, Shaw BE, Wingard JR. Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield. Blood Adv. 2020 Feb 25;4(4):706-716. PMID: 32092138

132. Epperla N, Li A, Logan B, Fretham C, Chhabra S, Aljurf M, Chee L, Copelan E, Freytes CO, Hematti P, Lazarus HM, Litzow M, Nishihori T, Olsson RF, Prestidge T, Saber W, Wirk B, Yared JA, Loren A, Pasquini M. Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy. Br J Haematol. 2020 Jun;189(6):1171-1181. PMID: 32124435

133. Lee CJ, Kim S, Tecca HR, Bo-Subait S, Phelan R, Brazauskas R, Buchbinder D, Hamilton BK, Battiwalla M, Majhail NS, Lazarus HM, Shaw PJ, Marks DI, Litzow MR, Chhabra S, Inamoto Y, DeFilipp Z, Hildebrandt GC, Olsson RF, Kasow KA, Liesveld JL, Rotz SJ, Badawy SM, Bhatt NS, Yared JA, Page KM, Arellano ML, Kent M, Farhadfar N, Seo S, Hematti P, Freytes CO, Rovó A, Ganguly S, Nathan S, Burns L, Shaw BE, Muffly LS. Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia. Blood Adv. 2020 Mar 24;4(6):983-992. PMID: 32168378

134. Jabbehdari S, Yazdanpanah G, Kanu LN, Chen E, Kang K, Anwar KN, Ghassemi M, Hematti P, Rosenblatt MI, Djalilian AR. Therapeutic Effects of Lyophilized Conditioned-Medium derived from Corneal Mesenchymal Stromal Cells on Corneal Epithelial Wound Healing. Curr Eye Res. 2020 Apr 27. doi: 10.1080/02713683.2020.1762227. [Epub ahead of print] PMID: 32338541

135. Mehta RS, Holtan SG, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Alousi AM, Pidala J, Abdel-Azim H, Agrawal V, Ahmed I, Al-Homsi AS, Aljurf M, Antin JH, Askar M, Auletta JJ, Bhatt VR, Chee L, Chhabra S, Daly A, DeFilipp Z, Gajewski J, Gale RP, Gergis U, Hematti P, Hildebrandt GC, Hogan WJ, Inamoto Y, Martino R, Majhail NS, Marks DI, Nishihori T, Olsson RF, Pawarode A, Diaz MA, Prestidge T, Rangarajan HG, Ringden O, Saad A, Savani BN, Schoemans H, Seo S, Schultz KR, Solh M, Spitzer T, Storek J, Teshima T, Verdonck LF, Wirk B, Yared JA, Cahn JY, Weisdorf DJ. Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT. J Clin Oncol. 2020 May 4:JCO1900396. doi: 10.1200/JCO.19.00396. [Epub ahead of print] PMID: 32364845

136. Kahn JM, Brazauskas R, Tecca HR, Bo-Subait S, Buchbinder D, Battiwala M, Flowers MED, Savani BN, Phelan R, Broglie L, Abraham AA, Keating AK, Daly A, Wirk B, George B, Alter BP, Ustun C, Freytes CO, Beitinjaneh AM, Duncan C, Copelan E, Hildebrandt GC, Murthy HS, Lazarus HM, Auletta JJ, Myers KC, Williams KM, Page KM, Vrooman LM, Norkin M, Byrne M, Diaz MA, Kamani N, Bhatt NS, Rezvani A, Farhadfar N, Mehta PA, Hematti P, Shaw PJ, Kamble RT, Schears R, Olsson RF, Hayashi RJ, Gale RP, Mayo SJ, Chhabra S, Rotz SJ, Badawy SM, Ganguly S, Pavletic S, Nishihori T, Prestidge T, Agrawal V, Hogan WJ, Inamoto Y, Shaw BE, Satwani P. Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases. Blood Adv. 2020 May 12;4(9):2084-2094. PMID: 32396620

137. Im A, Rashidi A, Wang T, Hemmer M, MacMillan ML, Pidala J, Jagasia M, Pavletic S, Majhail NS, Weisdorf D, Abdel-Azim H, Agrawal V, Al-Homsi AS, Aljurf M, Askar M, Auletta JJ, Bashey A, Beitinjaneh A, Bhatt VR, Byrne M, Cahn JY, Cairo M, Castillo P, Cerny J, Chhabra S, Choe H, Ciurea S, Daly A, Perez MAD, Farhadfar N, Gadalla SM, Gale R, Ganguly S, Gergis U, Hanna R, Hematti P, Herzig R, Hildebrandt GC, Lad DP, Lee C, Lehmann L, Lekakis L, Kamble RT, Kharfan-Dabaja MA, Khandelwal P, Martino R, Murthy HS, Nishihori T, O'Brien TA, Olsson RF, Patel SS, Perales MA, Prestidge T, Qayed M, Romee R, Schoemans H, Seo S, Sharma A, Solh M, Strair R, Teshima T, Urbano-Ispizua A, Van der Poel M, Vij R, Wagner JL, William B, Wirk B, Yared JA, Spellman SR, Arora M, Hamilton BK. Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide. Biol Blood Marrow Transplant. 2020 May 17:S1083-8791(20)30286-X. doi: 10.1016/j.bbmt.2020.05.001. Online ahead of print. PMID: 32434056

138. Hess NJ, Hudson AW, Hematti P, Gumperz JE. Early T Cell Activation Metrics Predict Graft-versus-Host Disease in a Humanized Mouse Model of Hematopoietic Stem Cell Transplantation. J Immunol. 2020 May 22:ji2000054. doi: 10.4049/jimmunol.2000054. Online ahead of print. PMID: 32444392

139. Frigault MJ, Nikiforow S, Mansour M, Hu ZH, Horowitz MM, Riches M, Hematti P, Turtle CJ, Zhang MJ, Perales MA, Pasquini MC. Tocilizumab not associated with increased infection risk after CAR T - Implications for COVID-19? Blood. 2020 Jul 2;136(1):137-139. PMID: 32457999

140. Liao R, Zheng Y, Liu X, Zhang Y, Seim G, Tanimura N, Wilson GM, Hematti P, Coon JJ, Fan J, Xu J, Keles S, Bresnick EH Discovering How Heme Controls Genome Function Through Heme-omics. Cell Rep. 2020 Jun 30;31(13):107832. doi: 10.1016/j. CellRep.2020.107832. PMID: 32610133

141. Solomon SR, Martin AS, Zhang MJ, Ballen K, Bashey A, Battiwalla M, Baxter-Lowe LA, Brunstein C, Chhabra S, Perez MAD, Fuchs EJ, Ganguly S, Hardy N, Hematti P, McGuirk J, Peres E, Ringden O, Rizzieri D, Romee R, Solh M, Szwajcer D, van der Poel M, Waller E, William BM, Eapen M. Optimal donor for African Americans with hematologic malignancy: HLA-haploidentical relative or umbilical cord blood transplant. Biol Blood Marrow Transplant. 2020 Oct;26(10):1930-1936. PMID: 32649981

142. D'Angelo CR, Hall A, Woo KM, Kim K, Longo W, Hematti P, Callander N, Kenkre VP, Mattison R, Juckett M. Decitabine induction with myeloablative conditioning and allogeneic hematopoietic stem cell transplantation in high-risk patients with myeloid malignancies is associated with a high rate of infectious complications. Leuk Res. 2020 Jul 8;96:106419. doi: 10.1016/j.leukres.2020.106419. Online ahead of print. PMID: 32683127

143. Weishar R, Lee MS, Fontana G, Hematti P, Li WJ. Endothelin-1 reduces catabolic activity of human mesenchymal stem/stromal cells during chondro- and osteo-lineage differentiation. Biochem Biophys Res Commun. 2020 Aug 20;529(2):180-185. PMID: 32703408

144. Jabbehdari S, Yazdanpanah G, Kanu LN, Anwar KN, Shen X, Rabiee B, Putra I, Eslani M, Rosenblatt MI, Hematti P, Djalilian AR. Reproducible Derivation and Expansion of Corneal Mesenchymal Stromal Cells for Therapeutic Applications. Transl Vis Sci Technol. 2020 Feb 21;9(3):26. doi: 10.1167/tvst.9.3.26. PMID: 32742756

145. Forsberg MH, Kink JA, Hematti P, Capitini CM Mesenchymal Stromal Cells and Exosomes: Progress and Challenges. Front Cell Dev Biol. 2020 Jul 17;8:665. doi: 10.3389/fcell.2020.00665. eCollection 2020. PMID: 32766255

146. Carlson K, Kink J, Hematti P, Al-Adra D. Extracellular Vesicles as a Novel Therapeutic Option in Liver Transplantation. Liver Transpl. 2020 Nov;26(11):1522-1531. PMID: 32844568

147. Chinnadurai R, Forsberg MH, Kink JA, Hematti P, Capitini CM Use of MSCs and MSC-educated macrophages to mitigate hematopoietic acute radiation syndrome. Curr Stem Cell Rep. 2020 Sep;6(3):77-85. doi: 10.1007/s40778-020-00176-0. Epub 2020 Aug 8. PMID: 32944493

148. Mushtaq MU, Harrington AM, Chaudhary SG, Michaelis LC, Carlson KB, Abedin S, Runass L, Callander NS, Fallon MJ, Juckett M, Hall AC, Hematti P, Mattison RJ, Atallah EL, Guru Murthy GS. Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia. Leuk Lymphoma. 2020 Sep 19:1-9. doi: 10.1080/10428194.2020.1821009. Online ahead of print. PMID: 32951486

149. Raval AN, Johnston PV, Duckers HJ, Cook TD, Traverse JH, Altman PA, Dhingra R, Hematti P, Borrello I, Anderson RD, Pepine CJ. Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort. Int J Cardiol. 2020 Oct 19:S0167-5273(20)33996-6. doi: 10.1016/j.ijcard.2020.10.043. Online ahead of print. PMID: 33091520

150. Chamberlain CS, Kink JA, Wildenauer LA, McCaughey M, Henry K, Spiker AM, Halanski MA, Hematti P, Vanderby R. Exosome-educated macrophages and exosomes differentially improve ligament healing. Stem Cells. 2020 Nov 3. doi: 10.1002/stem.3291. Online ahead of print. PMID: 33141458

151. Pasquini MC, Hu ZH, Curran K, Laetsch T, Locke F, Rouce R, Pulsipher MA, Phillips CL, Keating A, Frigault MJ, Salzberg D, Jaglowski S, Sasine JP, Rosenthal J, Ghosh M, Landsburg D, Margossian S, Martin PL, Kamdar MK, Hematti P, Nikiforow S, Turtle C, Perales MA, Steinert P, Horowitz MM, Moskop A, Pacaud L, Yi L, Chawla R, Bleickardt E, Grupp S. Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma. Blood Adv. 2020 Nov 10;4(21):5414-5424. PMID: 33147337

152. D'Souza SS, Bennett S, Kumar A, Kelnhofer LE, Weinfurter J, Suknuntha K, Coonen J, Mejia A, Simmons H, Golos T, Hematti P, Capitini CM, Reynolds MR, Slukvin II. Transplantation of TCRα/β-depleted allogeneic bone marrow in nonhuman primates. Exp Hematol. 2020 Nov 8:S0301-472X(20)30563-4. doi: 10.1016/j.exphem.2020.09.198. Online ahead of print. PMID: 33176119

153. Hess NJ, Lindner PN, Vazquez J, Grindel S, Hudson AW, Stanic AK, Ikeda A, Hematti P, Gumperz JE. Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source. Front Immunol. 2020 Oct 19;11:573406. doi: 10.3389/fimmu.2020.573406. eCollection 2020.PMID: 33193358

154. Heninger E, Sethakorn N, Kosoff D, Hematti P, Kuczler MD, Pienta KJ, Lang JM. Immune profiling of the bone marrow microenvironment in patients with high-risk localized prostate cancer. Oncotarget. 2020 Nov 17;11(46):4253-4265. doi: 10.18632/oncotarget.27817. eCollection 2020 Nov 17. PMID: 33245727

155. Schmuck EG, Roy S, Dhillon A, Walker S, Spinali K, Colevas S, Zhou T, Chhabra G, Liu Y, Kader Sagar MA, Childs CJ, Kink JA, Eliceiri KW, Hematti P, Raval AN. Cultured Cardiac Fibroblasts and Myofibroblasts Express Sushi Containing Domain 2 and Assemble a Unique Fibronectin Rich Matrix. Exp Cell Res. 2021 Jan 13:112489. doi: 10.1016/j.yexcr.2021.112489. Online ahead of print. PMID: 33453237

156. Roy S, Spinali K, Schmuck EG, Kink JA, Hematti P, Raval AN. Cardiac fibroblast derived matrix-educated macrophages express VEGF and IL-6, and recruit mesenchymal stromal cells. J Immunol Regen Med. 2020 Dec;10:100033. doi: 10.1016/j.regen. 2020.100033. Epub 2020 Oct 21. PMID: 33564732

157. Denu RA, Hematti P. Optimization of oxidative stress for mesenchymal stromal/stem cell engraftment, function and longevity. Free Radic Biol Med. 2021 May 1;167:193-200. PMID: 33677063

158. Rentscher KE, Carroll JE, Juckett MB, Coe CL, Broman AT, Rathouz PJ, Hematti P, Costanzo ES. Sleep Disruption, Fatigue, and Depression as Predictors of 6-Year Clinical Outcomes following Allogeneic Hematopoietic Cell Transplantation. J Natl Cancer Inst. 2021 Oct 1;113(10):1405-1414. PMID: 33693799

159. Farhadfar N, Dias A, Wang T, Fretham C, Chhabra S, Murthy HS, Broglie L, D'Souza A, Gadalla SM, Gale RP, Hashmi S, Al-Homsi AS, Hildebrandt GC, Hematti P, Rizzieri D, Chee L, Lazarus HM, Bredeson C, Jaimes EA, Beitinjaneh A, Bashey A, Prestidge T, Krem MM, Marks DI, Benoit S, Yared JA, Nishihori T, Olsson RF, Freytes CO, Stadtmauer E, Savani BN, Sorror ML, Ganguly S, Wingard JR, Pasquini M. Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation. Transplant Cell Ther. 2021 May;27(5):410-422.PMID: 33775617

160. Panch SR, Logan B, Sees JA, Bo-Subait S, Savani B, Shah NN, Hsu JW, Switzer G, Lazarus HM, Anderlini P, Hematti P, Confer D, Pulsipher MA, Shaw BE, Stroncek DF. Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell Donations. Transplant Cell Ther. 2021 Jun;27(6):503.e1-503.e8. doi: 10.1016/j.jtct.2021.03.008. Epub 2021 Mar 9. PMID: 33823169

161. Nguyen-Truong M, Hematti P, Wang Z. Current Status of Myocardial Restoration via the Paracrine Function of Mesenchymal Stromal Cells. Am J Physiol Heart Circ Physiol. 2021 Jul 1;321(1):H112-H127. PMID: 34085844

162. Shahzad M, Siddiqui RS, Anwar I, Chaudhary SG, Ali T, Naseem M, Ahmed TF, Ahmed Z, Khurana S, Ahmed N, Balusu R, Singh AK, Hematti P, Callander NS, Abhyankar SH, McGuirk JP, Mushtaq MU. Outcomes with CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis. Transplant Cell Ther. 2021 Oct;27(10):877.e1-877.e8. doi: 10.1016/j.jtct.2021.07.012. Epub 2021 Jul 18. PMID: 34284148

163. Putra I, Shen X, Anwar KN, Rabiee B, Samaeekia R, Almazyad E, Giri P, Jabbehdari S, Hayat MR, Elhusseiny AM, Ghassemi M, Mahmud N, Edward DP, Joslin CE, Rosenblatt MI, Dana R, Eslani M, Hematti P, Djalilian AR. Preclinical Evaluation of the Safety and Efficacy of Cryopreserved Bone Marrow Mesenchymal Stromal Cells for Corneal Repair. Transl Vis Sci Technol. 2021 Aug 12;10(10):3. doi: 10.1167/tvst.10.10.3. PMID: 34383879

164. Forrest L, Fechner J, Post J, Van Asselt N, Kvasnica K, Haynes LD, Coonen J, Brunner K, Haynes WJ, Little C, Burlingham WJ, Hematti P, Strober S, Kaufman DB. Tomotherapy Applied Total Lymphoid Irradiation and Allogeneic Hematopoietic Cell Transplantation Generates Mixed Chimerism in the Rhesus Macaque Model. Radiat Res. 2021 Dec 1;196(6):623-632. PMID: 34388816

165. Forsberg MH, Kink JA, Thickens AS, Lewis BM, Childs CJ, Hematti P, Capitini CM. Exosomes from primed MSCs can educate monocytes as a cellular therapy for hematopoietic acute radiation syndrome. Stem Cell Res Ther. 2021 Aug 18;12(1):459. doi: 10.1186/s13287-021-02491-7. PMID: 34407878

166. Orfali N, Zhang MJ, Allbee-Johnson M, Boelens JJ, Artz AS, Brunstein CG, McNiece IK, Milano F, Abid MB, Chee L, Diaz MA, Grunwald MR, Hematti P, Hsu J, Lazarus HM, Munshi PN, Prestidge T, Ringden O, Rizzieri D, Riches ML, Seo S, Solh M, Solomon S, Szwajcer D, Yared J, Besien KV, Eapen M. Planned granulocyte-colony stimulating factor adversely impacts survival after allogeneic hematopoietic cell transplantation performed with Thymoglobulin for myeloid malignancy. Transplant Cell Ther. 2021 Dec;27(12):993.e1-993.e8. doi: 10.1016/j.jtct.2021.08.031. Epub 2021 Oct 2. PMID: 34507002

167. Shadman M, Pasquini MC, Ahn KW, Chen Y, Turtle CJ, Hematti P, Cohen JB, Khimani F, Ganguly S, Merryman RW, Yared JA, Locke FL, Ahmed N, Munshi P, Beitinjaneh A, Reagan P, Herrera AF, Sauter CS, Kharfan-Dabaja MA, Hamadani M. Autologous Transplant versus Chimeric Antigen Receptor T-cell Therapy for Relapsed DLBCL in Partial Remission. Blood. 2022 Mar 3;139(9):1330-1339. PMID: 34570879

168. Singh A, Dandoy CE, Chen M, Kim S, Mulroney CM, Kharfan-Dabaja MA, Ganguly S, Maziarz RT, Kanakry CG, Kanakry JA, Patel SS, Hill JA, De Oliveira S, Taplitz R, Hematti P, Lazarus HM, Abid MB, Goldsmith SR, Romee R, Komanduri KV, Badawy SM, Friend BD, Beitinjaneh A, Politikos I, Perales MA, Riches M. Post-Transplant cyclophosphamide is associated with increase in Non-CMV Herpesvirus infections in Acute leukemia and MDS patients. Transplant Cell Ther. 2022 Jan;28(1):48.e1-48.e10. doi: 10.1016/j.jtct.2021.09.015. Epub 2021 Sep 26. PMID: 34587551

169. Hamadani M, Gopal AK, Pasquini MC, Kim S, Qiu X, Ahmed S, Lazaryan A, Bhatt VR, Daly A, Lulla P, Ciurea SO, Gauthier J, Agrawal V, Grover NS, Lekakis LJ, Modi D, Dahi PB, Herr MM, Johnson PC, Hashmi H, Hematti P, Locke FL. Allogeneic Transplant and CAR-T Therapy After Autologous Transplant Failure in DLBCL: A Noncomparative Cohort Analysis. Blood Adv. 2022 Jan 25;6(2):486-494. PMID: 34673903

170. Phelan R, Im A, Hunter RL, Inamoto Y, Lupo-Stanghellini MT, Rovo A, Badawy SM, Burns L, Eissa H, Murthy HS, Prasad P, Sharma A, Suelzer E, Agrawal V, Aljurf M, Baker K, Basak GW, Buchbinder D, DeFilipp Z, Grkovic LD, Dias A, Einsele H, Eisenberg ML, Epperla N, Farhadfar N, Flatau A, Gale RP, Greinix H, Hamilton BK, Hashmi S, Hematti P, Jamani K, Maharaj D, Murray J, Naik S, Nathan S, Pavletic S, Peric Z, Pulanic D, Ross R, Salonia A, Sanchez-Ortega I, Savani BN, Schechter T, Shah AJ, Smith SM, Snowden JA, Steinberg A, Tremblay D, Vij SC, Walker L, Wolff D, Yared JA, Schoemans H, Tichelli A. Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. Transplant Cell Ther. 2021 Oct 29:S2666-6367(21)01329-4. doi: 10.1016/j.jtct.2021.10.013. Online ahead of print. PMID: 34757220

171. Chinnadurai R, Porter AP, Patel M, Lipat AJ, Forsberg MH, Rajan D, Hematti P, Capitini CM, Bruker C. Hepatocellular Carcinoma Cells Are Protected From Immunolysis by Mesenchymal Stromal Cells Through Indoleamine 2,3 Dioxygenase. Front Cell Dev Biol. 2021 Nov 12;9:715905. eCollection 2021. PMID: 34869307

172. Shahzad M, Chaudhary SG, Zafar MU, Hassan MA, Hussain A, Ali F, Anwar I, Ahmed M, Ahmed N, Khurana S, Rauf MA, Anwar F, Hematti P, Callander NS, Abhyankar SH, McGuirk JP, Mushtaq MU. Impact of COVID-19 in Hematopoietic stem cell transplant recipients: A systematic review and meta-analysis. Transpl Infect Dis. 2022 Apr;24(2):e13792. PMID: 35030267

173. Siddiqui RS, Chaudhary SG, Shahzad M, Anwar I, Hussain A, Ahmed N, Abhyankar SH, Shune L, Hematti P, Male H, Khosa F, Lin T, McGuirk JP, Callander NS, Mushtaq MU. Gender disparities in the National Institutes of Health funding for hematologic malignancies and cellular therapies. Leuk Lymphoma. Leuk Lymphoma. 2022 Jul;63(7):1708-1713. PMID: 35142581

174. Abou-Ismail MY, Fraser R, Allbee-Johnson M, Metheny L 3rd, Ravi G, Ahn KW, Bhatt NS, Lazarus HM, de Lima M, El Jurdy N, Hematti P, Beitinjaneh AM, Nishihori T, Badawy SM, Sharma A, Pasquini MC, Savani BN, Sorror ML, Stadtmauer EA, Chhabra S. Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation? Br J Haematol. 2022 May;197(3):326-338. PMID: 35286719

175. Nguyen-Truong M, Kim S, Doherty C, Frederes M, LeBar K, Ghosh S, Hematti P, Chinnadurai R, Wagner WR, Wang Z. Pro-angiogenic Potential of Mesenchymal Stromal Cells Regulated by Matrix Stiffness and Anisotropy Mimicking Right Ventricles. Biomacromolecules. 2022 Jun 13;23(6):2353-2361. PMID: 35502841

176. Phelan R, Im A, Hunter RL, Inamoto Y, Lupo-Stanghellini MT, Rovo A, Badawy SM, Burns L, Eissa H, Murthy HS, Prasad P, Sharma A, Suelzer E, Agrawal V, Aljurf M, Baker K, Basak GW, Buchbinder D, DeFilipp Z, Grkovic LD, Dias A, Einsele H, Eisenberg ML, Epperla N, Farhadfar N, Flatau A, Gale RP, Greinix H, Hamilton BK, Hashmi S, Hematti P, Jamani K, Maharaj D, Murray J, Naik S, Nathan S, Pavletic S, Peric Z, Pulanic D, Ross R, Salonia A, Sanchez-Ortega I, Savani BN, Schechter T, Shah AJ, Smith SM, Snowden JA, Steinberg A, Tremblay D, Vij SC, Walker L, Wolff D, Yared JA, Schoemans H, Tichelli A. Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. Bone Marrow Transplant. 2022 May 6. Online ahead of print. PMID: 35523848

177. Mark C, Warrick J, Callander NS, Hematti P, Miyamoto S. A Hyaluronan and Proteoglycan Link Protein 1 Matrikine: Role of Matrix Metalloproteinase 2 in Multiple Myeloma NF-κB Activation and Drug Resistance. Mol Cancer Res. 2022 May 23:molcanres.0941.2021. Online ahead of print. PMID: 35604822

178. Kirvin-Quamme A, Rumble ME, Cadmus-Bertram L, Juckett MB, Rathouz PJ, Schell G, Callander NS, Hematti P, Costanzo ES. A biobehavioral intervention to enhance recovery following hematopoietic cell transplantation: Protocol for a feasibility and acceptability randomized control trial. Contemp Clin Trials Commun. 2022 May 28;28:100938. doi: 10.1016/j.conctc.2022.100938. eCollection 2022 Aug. PMID: 3566450

179. Khanam R, Shahzad M, Chaudhary SG, Ali F, Shah Z, Pachika PS, Ahmed Z, Chattaraj A, Masood A, Ahmed N, Bansal R, Balusu R, Shune L, Anwar F, Hematti P, McGuirk JP, Yacoub A, Mushtaq MU. Outcomes after venetoclax with hypomethylating agents in myelodysplastic syndromes: a systematic review and meta-analysis. Leuk Lymphoma. 2022 Nov;63(11):2671-2678. PMID: 35687838

180. Shahzad M, Chaudhary SG, Anwar I, Arslan M, Naseem Z, Fatima NT, Abbas S, Ali T, Siddiqui RS, Hematti P, Abhyankar SH, McGuirk JP, Mushtaq MU. Top 100 Cited Articles on Clinical Hematopoietic Stem Cell Transplantation: A Bibliometric Analysis. Front Med (Lausanne). 2022 Jun 6;9:872692. doi: 10.3389/fmed.2022.872692. eCollection 2022. PMID: 35733859

181. Weinfurter JT, D'Souza SS, Matschke LM, Bennett S, Kelnhofer-Millevolte LE, Suknuntha K, Kumar A, Coonen J, Capitini CM, Hematti P, Golos TG, Slukvin II, Reynolds MR. Allogeneic MHC-matched T-cell receptor α/β-depleted bone marrow transplants in SHIV-infected, ART-suppressed Mauritian cynomolgus macaques. Sci Rep. 2022 Jul 19;12(1):12345. PMID: 35853970

182. Saliba RM, Majid AA, Pidala J, Arora M, Spellman SR, Hemmer MT, Wang T, Abboud C, Ahmed S, Antin JH, Beitinjaneh A, Buchbinder D, Byrne M, Cahn JY, Choe H, Hanna R, Hematti P, Kamble RT, Kitko CL, Laughlin M, Lekakis L, MacMillan ML, Martino R, Mehta PA, Nishihori T, Patel SS, Perales MA, Rangarajan HG, Ringdén O, Rosenthal J, Savani BN, Schultz KR, Seo S, Teshima T, van der Poel M, Verdonck LF, Weisdorf D, Wirk B, Yared JA, Schriber J, Champlin R, Ciurea S. Characteristics of Graft-versus-Host Disease (GvHD) after Post-transplant Cyclophosphamide versus Conventional GvHD Prophylaxis. Transplant Cell Ther. 2022 Oct;28(10):681-693. PMID: 35853610

183. Lee CJ, Wang T, Chen K, Arora M, Brazauskas R, Spellman SR, Kitko C, MacMillan ML, Pidala JA, Auletta JJ, Badawy SM, Bhatt N, Bhatt VR, Cahn JY, DeFilipp Z, Diaz MA, Farhadfar N, Gadalla S, Gale RP, Hashem H, Hashmi S, Hematti P, Hong S, Hossain NM, Inamoto Y, Lekakis LJ, Modi D, Patel S, Sharma A, Solomon S, Couriel DR. Association of Chronic Graft-versus-Host Disease with Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy. Transplant Cell Ther. 2022 Jul 18. Online ahead of print. PMID: 35863740

184. Lipat AJ, Cottle C, Pirlot BM, Mitchell J, Pando B, Helmly B, Kosko J, Rajan D, Hematti P, Chinnadurai R. Chemokine Assay Matrix Defines the Potency of Human Bone Marrow Mesenchymal Stromal Cells. Stem Cells Transl Med. 2022 Jul 26: Online ahead of print. PMID: 35881077

185. Jalilian E, Massoumi H, Bigit B, Amin S, Katz EA, Guaiquil VH, Anwar KN, Hematti P, Rosenblatt MI, Djalilian AR. Bone marrow mesenchymal stromal cells in a 3D system produce higher concentration of extracellular vesicles (EVs) with increased complexity and enhanced neuronal growth properties. Stem Cell Res Ther. 2022 Aug 19;13(1):425. PMID: 35986305

186. Porter AP, Pirlot BM, Dyer K, Uwazie CC, Nguyen J, Turner C, Rajan D, Hematti P, Chinnadurai R. Conglomeration of T and B Cell Matrix Responses Determines the Potency of Human Bone Marrow Mesenchymal Stromal Cells. Stem Cells. 2022 Sep 3: Online ahead of print. PMID: 36056823

187. Sethakorn N, Heninger E, Breneman MT, Recchia E, Ding AB, Jarrard DF, Hematti P, Beebe DJ, Kosoff D. Integrated analysis of the tumor microenvironment using a reconfigurable microfluidic cell culture platform. FASEB J. 2022 Oct;36(10):e22540. PMID: 36083096

188. Shahzad M, Tariq E, Chaudhary SG, Anwar I, Iqbal Q, Fatima H, Abdelhakim H, Ahmed N, Balusu R, Hematti P, Singh AK, McGuirk JP, Mushtaq MU. Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated acute myeloid leukemia: a systematic review and meta-analysis. Leuk Lymphoma. 2022 Sep 15:1-9. Online ahead of print. PMID: 36107118

189. D'Angelo C, Sudakaran S, Asimakopoulos F, Hematti P, El-Gamal D, Safdar N, Callander N. Perturbation of the gut microbiome and association with outcomes following autologous stem cell transplantation in patients with multiple myeloma. Leuk Lymphoma. 2022 Oct 11:1-11. Online ahead of print. PMID: 36218226

190. Mushtaq MU, Shahzad M, Shah AY, Chaudhary SG, Zafar MU, Anwar I, Neupane K, Khalid A, Ahmed N, Bansal R, Balusu R, Singh AK, Abhyankar SH, Callander NS, Hematti P, McGuirk JP. Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis. Front Immunol. 2022 Oct 3; eCollection 2022. PMID: 36263054

191. Mushtaq MU, Shahzad M, Tariq E, Iqbal Q, Chaudhary SG, Zafar MU, Anwar I, Ahmed N, Bansal R, Singh AK, Abhyankar SH, Callander NS, Hematti P, McGuirk JP. Outcomes with mismatched unrelated donor allogeneic hematopoietic stem cell transplantation in adults: A systematic review and meta-analysis. Front Oncol. 2022 Oct 6; eCollection 2022. PMID: 36276084

192. Shahzad M, Chaudhary SG, Tariq E, Mushtaq AH, Anwar I, Ahmed N, Bansal R, Lutfi F, Balusu R, Abdelhakim H, Yacoub A, Hematti P, Singh AK, McGuirk JP, Mushtaq MU. Use of endpoints in phase III randomized controlled trials for acute myeloid leukemia over the last 15 years: a systematic review. Leuk Lymphoma. 2022 Oct 25:1-10. doi: 10.1080/10428194.2022.2136947. Online ahead of print. PMID: 36282773

193. Ramanathan M, Kim S, He N, Chen M, Hematti P, Abid MB, Rotz SJ, Williams KM, Lazarus HM, Wirk B, Yin DE, Kanakry CG, Perales MA, Chemaly RF, Dandoy CE, Riches M, Ustun C. The incidence and impact of clostridioides difficile infection on transplant outcomes in acute leukemia and MDS after allogeneic hematopoietic cell transplant-a CIBMTR study. Bone Marrow Transplant. 2022 Dec 21. Online ahead of print. PMID: 36543999

194. Shahzad M, Hussain A, Tariq E, Anwar I, Faisal MS, Syed L, Karam A, Chaudhary SG, Ahmed N, Bansal R, Khurana S, Singh AK, Byrd KP, Hematti P, Abhyankar SH, McGuirk JP, Mushtaq MU. Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-Analysis. Clin Lymphoma Myeloma Leuk. 2023 Jan 12:S2152-2650(23)Online ahead of print. PMID: 36682989

195. Hansen JL, Juckett MB, Foster MA, Rumble ME, Morris KE, Hematti P, Costanzo ES. Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host disease. J Cancer Surviv. 2023 Jun;17(3):646-656. PMID: 36917433. Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host disease

196. Wilson N, Reese S, Ptak L, Aziz F, Parajuli S, Jucaud V, Denham S, Mishra A, Cascalho M, Platt JL, Hematti P, Djamali A. Ixazomib for Desensitization (IXADES) in Highly Sensitized Kidney Transplant Candidates: A Phase II Clinical Trial. Kidney360. 2023 Mar 23. Online ahead of print. PMID: 36951387

197. Hess NJ, Turicek DP, Riendeau J, McIlwain SJ, Contreras Guzman E, Nadiminti K, Hudson A, Callander NS, Skala MC, Gumperz JE, Hematti P, Capitini CM. Inflammatory CD4/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology. Sci Adv. 2023 Mar 24;9(12): Epub 2023 Mar 24. PMID: 36961891

198. Hess NJ, Kink JA, Hematti P. Exosomes, MDSCs and Tregs: A new frontier for GVHD prevention and treatment. Front Immunol. 2023 Mar 29;14:1143381. eCollection 2023. PMID: 37063900

199. Shahzad M, Nguyen A, Hussain A, Ammad-Ud-Din M, Faisal MS, Tariq E, Ali F, Butt A, Anwar I, Chaudhary SG, Lutfi F, Ahmed N, Singh AK, Hematti P, McGuirk JP, Mushtaq MU. Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis. Front Immunol. 2023 Apr 24;14:1152457. eCollection 2023. PMID: 37168849

200. Uwazie CC, Faircloth TU, Parr RN, Reddy YU, Hematti P, Rajan D, Chinnadurai R. Contrariety of Human Bone Marrow Mesenchymal Stromal Cell Functionality in Modulating Circulatory Myeloid and Plasmacytoid Dendritic Cell Subsets. Biology (Basel). 2023 May 16;12(5):725. PMID: 37237538

201. Massoumi H, Amin S, Soleimani M, Momenaei B, Ashraf MJ, Guaiquil VH, Hematti P, Rosenblatt MI, Djalilian AR, Jalilian E. Extracellular-Vesicle-Based Therapeutics in Neuro-Ophthalmic Disorders. Int J Mol Sci. 2023 May 19;24(10):9006. PMID: 37240353

202. Nelson AM, Erdmann AA, Coe CL, Juckett MB, Morris K, Knight JM, Hematti P, Costanzo ES. Inflammatory Cytokines and Depression Symptoms Following Hematopoietic Cell Transplantation. Brain Behav Immun. 2023 May 24:S0889-1591(23)00130-7. PMID: 37236325

203. Kaufman DB, Forrest LJ, Fechner J, Post J, Coonen J, Haynes LD, Haynes WJ, Christensen N, Zhong W, Little CJ, D'Alessandro A, Fernandez L, Brunner K, Jensen K, Burlingham WJ, Hematti P, Strober S. Helical TomoTherapy Total Lymphoid Irradiation and Hematopoietic Cell Transplantation for Kidney Transplant Tolerance in Rhesus Macaques. Transpl Int. 2023 Jun 22;36:11279. eCollection 2023. PMID: 37426429 PMCID: PMC10324513

204. Chung DJ, Shah N, Wu J, Logan B, Bisharat L, Callander N, Cheloni G, Anderson K, Chodon T, Dhakal B, Devine S, Somaiya Dutt P, Efebera Y, Geller N, Ghiasuddin H, Hematti P, Holmberg L, Howard A, Johnson B, Karagkouni D, Lazarus HM, Malek E, McCarthy P, McKenna D, Mendizabal A, Nooka A, Munshi N, O'Donnell L, Rapoport AP, Reese J, Rosenblatt J, Soiffer R, Stroopinsky D, Uhl L, Vlachos IS, Waller EK, Young JW, Pasquini MC, Avigan D. Randomized Trial of a Personalized Dendritic Cell Vaccine after Autologous Stem Cell Transplant for Multiple Myeloma. Clin Cancer Res. 2023 Jul 18:CCR-23-0235. Online ahead of print. PMID: 37463058

205. Uwazie CC, Pirlot BM, Faircloth TU, Patel M, Parr RN, Zastre HM, Hematti P, Moll G, Rajan D, Chinnadurai R. Effects of Atrazine exposure on human bone marrow-derived mesenchymal stromal cells assessed by combinatorial assay matrix. Front Immunol. 2023 Jul 31;14:1214098. eCollection 2023.PMID: 37588595

206. Papanicolaou GA, Chen M, He N, Martens MJ, Kim S, Batista MV, Bhatt NS, Hematti P, Hill JA, Liu H, Nathan S, Seftel MD, Sharma A, Waller EK, Wingard JR, Young JH, Dandoy CE, Perales MA, Chemaly RF, Riches M, Ustun C. Incidence and impact of fungal infections in post-transplant Cyclophosphamide (PTCy)-based graft-versus-host disease prophylaxis and haploidentical hematopoietic cell transplantation: A CIBMTR analysis. Transplant Cell Ther. 2023 Sep 27:S2666-6367(23)01556-7. Online ahead of print. PMID: 37775070

207. Lee CJ, Wang T, Chen K, Arora M, Brazauskas R, Spellman SR, Kitko C, MacMillan ML, Pidala JA, Badawy SM, Bhatt N, Bhatt VR, DeFilipp Z, Diaz MA, Farhadfar N, Gadalla S, Hashmi S, Hematti P, Hossain NM, Inamoto Y, Lekakis LJ, Sharma A, Solomon S, Lee SJ, Couriel DR. Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy. Transplant Cell Ther. 2023 Oct 14:S2666-6367(23)01614-7. Online ahead of print. PMID: 37844687

208. Zinter MS, Brazauskas R, Strom J, Chen S, Bo-Subait S, Sharma A, Beitinjaneh A, Dimitrova D, Guilcher G, Preussler J, Myers K, Bhatt NS, Ringden O, Hematti P, Hayashi RJ, Patel S, De Oliveira SN, Rotz S, Badawy SM, Nishihori T, Buchbinder D, Hamilton B, Savani B, Schoemans H, Sorror M, Winestone L, Duncan C, Phelan R, Dvorak CC. Critical Illness Risk and Long-Term Outcomes Following Intensive Care in Pediatric Hematopoietic Cell Transplant Recipients. medRxiv. 2023 Aug 5:2023.07.31.23293444. doi: 10.1101/2023.07.31.23293444. Preprint. PMID: 37577706

209. Mishra AK, Schmidt TM, Martell EB, Chen AS, Dogru RE, Hematti P, Callander NS. PD1+TIGIT+2B4+KLRG1+ cells might underlie T-cell dysfunction in patients treated with BCMA-directed CAR-T therapy. Transplant Cell Ther. 2023 Nov 13:S2666-6367(23)01681-0. Online ahead of print. PMID: 37967650

210. Zinter MS, Brazauskas R, Strom J, Chen S, Bo-Subait S, Sharma A, Beitinjaneh A, Dimitrova D, Guilcher G, Preussler JM, Myers KC, Bhatt NS, Ringden O, Hematti P, Hayashi RJ, Patel SS, De Oliveira S, Rotz SJ, Badawy SM, Nishihori T, Buchbinder DK, Hamilton BK, Savani BN, Schoemans HM, Sorror ML, Winestone LE, Duncan C, Phelan R, Dvorak CC. Intensive Care Risk and Long-Term Outcomes in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients. Blood Adv. 2023 Dec 21: bloodadvances. 2023011002. doi: 10.1182/bloodadvances.2023011002. Online ahead of print. PMID: 38127268

1. Haririan A, Broumand B, Kiabi MH, Hematti P. Outcome of treatment in membranous Lupus nephritis in Iran. Current Therapy in Nephrology. 1992, Milano, Italy

2. Raissi S, Broumand B, Hematti P. Colchicine trial in renal amyloidosis in Iran. Current Therapy in Nephrology.1992; Milano, Italy

3. Haririan A, Broumand B, Hematti P, Kiabi MH. Treatment results of Type-I MPGN in Iran. Current Therapy in Nephrology. 1992; Milano, Italy

4. Raissi S, Broumand B, Hematti P, Haririan A. Renal amyloidosis in Iran. 9th Asian Colloquium in Nephrology. 1992; Seoul, Korea

5. Kiabi MH, Broumand B, Hematti P, Haririan A. Membranous Lupus nephritis in Iran. 9th Asian Colloquium in Nephrology. 1992; Seoul, Korea

6. Broumand B, Haririan A, Raissi S, Hematti P, Antonovych T, Sabnis SG. Features of MPGN in Iran. XIth International Congress of Nephrology. 1990; Tokyo, Japan

7. Broumand B, Ganji MR, Raissi S, Hematti P, Antonovych T, Sabnis SG. Results of steroid therapy in 42 patients with primary membranous GN. XIth International Congress of Nephrology. 1990; Tokyo, Japan

8. Hematti P, Hoeltge GA, Rybicki LA, Lichtin AE. Prognostic significance of standard Philadelphia chromosome versus Philadelphia chromosome with additional chromosomal abnormalities on survival of patients with chronic myelogenous leukemia. 39th Annual meeting of the American Society of Hematology, December 1997; San Diego, California

9. Hematti P, Rybicki LA, Hoeltge GA, Lichtin LA. Survival analysis of conventional chemotherapy versus Interferon-alpha treatment in patients with Chronic Myelogenous Leukemia. 39th Annual meeting of the American Society of Hematology, Dec.1997; San Diego, California

10. Hematti P, Sellers SE, Agricola BA, Metzger ME, Donahue RE, Dunbar CE. Retroviral transduction efficiency of rhesus macaque G-CSF-SCF mobilized CD34+ peripheral blood cells is superior to G-CSF alone or G-CSF+Flt3-L mobilized cells. 43rd Annual meeting of the American Society of Hematology. December 2001; Orlando, Florida

11. Hematti P, Sloand EM, Albert MR, Yee CL, Childs RW, Barrett JA, Vogel JC, Dunbar CE. Identification of keratinocyte stem cells originating from the donor graft following mobilized peripheral blood allogeneic transplantation. 43rd Annual meeting of the American Society of Hematology. December 2001; Orlando, Florida

12. Albert MR, Hematti P, Yee CL, Sloand E, Childs RW, Carvallo CA, Barrett JA, Dunbar C, Vogel JC. Lack of culture expansion of donor-derived keratinocytes from skin biopsies of patients with graft-vs.-host disease. 63rd Annual meeting of The Society for Investigative Dermatology. May 2002, Los Angeles, California

13. Hematti P, Tuchman SA, Agricola BA, Metzger ME, Donahue RE, Dunbar CE, Tisdale JF. Comparison of retroviral transduction efficiency of rhesus macaque bone marrow CD34+ cells versus G-CSF or G-CSF plus SCF mobilized peripheral blood CD34+ cells. 44th Annual meeting of the American Society of Hematology. December 2002; Philadelphia, Pennsylvania

14. Hanawa H, Hematti P, Persons DA, Dunbar CE, Nienhuis AW Development of an SIV-based lentiviral vector system for transduction of rhesus, primitive hematopoietic cells. 6th Annual meeting of the American Society of Gene Therapy. June 2003; Washington, DC

15. Sellers SE, Tisdale SF, Hematti P, Kuramoto K, Adler R, Laukkanen M, Calmels B, Takatoku M, Hu J, Wu T, Shi P, Agricola BA, Metzger ME, West E, Bonifacino A, An DS, Chen ISY, Donahue RE, Dunbar CE. Long-term follow-up of rhesus macaques receiving CD34+cells transduced with retroviral or lentiviral vectors. 6th Annual meeting of the American Society of Gene Therapy. June 2003; Washington, DC

16. Kuramoto K, Laukkanen MO, Sellers SE, Hematti P, Adler RL, Metzger M, Krouse A, Donahue R, von Kalle C, Dunbar CE. Low-dose Busulfan markedly impacts on in vivo hematopoietic stem cell dynamics: A genetic tracking analysis. 6th Annual meeting of the American Society of Gene Therapy. June 2003; Washington, DC

17. Candotti F, Podsakoff G, Schurman SH, Muul LM, Engel BC, Carbonaro DA, Jagadeesh GJ, Hematti P, Tuschong LM, Carter CS, Ramsey WJ, Choi C, Smogorzewska M, Hershfield MS, Read EJ, Tisdale JF, Dunbar CE, Kohn DB. Corrective gene transfer into bone marrow CD34+cells for adenosine deaminase (ADA) deficiency: Results in four patients after one year of follow-up. 6th Annual meeting of the American Society of Gene Therapy. June 2003; Washington, DC

18. Adler R, Hematti P, Calmels B Keyvanfar K, Kuramoto K, Sellers SE, von Kalle C, and Dunbar C. Analysis of clonal contribution to T lymphoid and myeloid lineages during recovery from autologous transplantation in the rhesus macaque. 44th Annual meeting of the American Society of Hematology. December 2002; Philadelphia, Pennsylvania

19. Hematti P, Hanawa H, Keyvanfar K, Krouse A, Donahue R, Persons D, Dunbar C, Nienhuis R. Transduction of rhesus macaque hematopoietic stem cells with an SIV-based lentiviral vector results in high level in vivo marking. 45th Annual meeting of the American Society of Hematology. December 2003; San Diego, California

20. Andre Larochelle, Allen Krouse, Donald Orlic, Robert Donahue, Cynthia Dunbar, Hematti P. The Use of AMD3100 Mobilized peripheral blood stem cell CD34+ targets for retroviral transduction results in high-level in vivo marking in rhesus macaques. 45th Annual meeting of the American Society of Hematology. December 2003; San Diego, California

21. Larochelle A, Krouse A, Orlic D, Donahue RE, Dunbar CE, Hematti P. AMD3100-mobilized CD34+ cells are phenotypically different and better targets for retroviral transduction than G-CSF-mobilized CD34+ cells in rhesus macaques. 7th Annual meeting of the American Society of Gene Therapy. June 2004; Minneapolis, Minnesota

22. Hong BK, Calmels B, Hanawa H, Gray J, Donahue RE, Persons DA, Nienhuis AW, Hematti P, Dunbar CE. Retroviral insertion site analysis in rhesus macaques transplanted with CD34+ hematopoietic stem cells transduced with a Simian Immunodeficiency Virus-based lentiviral vector7th Annual meeting of the American Society of Gene Therapy. June 2004; Minneapolis, Minnesota

23. Calmels B, Ferguson C, Adler R, Sellers S, Laukkanen M, Hematti P, Donahue R, and Dunbar C. Recurrent retroviral vector integration at the MDS1-EVI1 locus in rhesus long-term repopulating hematopoietic stem cells. 46th Annual meeting of the American Society of Hematology. December 2004; San Diego, California

24. Adler R, Hematti P, Calmels B, Ferguson C, Keyvanfar K, Wu C, Follmann D, Dunbar C. Analysis of clonal contributions to T lymphoid and myeloid lineages during early hematopoiesis following autologous transplantation in the rhesus macaque. 46th Annual meeting of the American Society of Hematology. Dec 2004; San Diego, California

25. Larochelle A, Krouse A, Orlic D, Donahue R, Dunbar C, Hematti P. AMD3100-mobilized CD34+ cells are phenotypically different and Better targets for retroviral transduction than G-CSF-mobilized CD34+ cells in rhesus macaques. 46th Annual meeting of the American Society of Hematology. December 2004; San Diego, California

26. Adler R, Hematti P, Calmels B, Ferguson C, Keyvanfar K, Wu C, Follmann D, Colin W, Dunbar C. Analysis of clonal contributions to T lymphoid and myeloid lineages during early hematopoiesis following autologous transplantation in the rhesus macaque. 3rd Annual meeting of the International Society for Stem Cell Research. June 2005; San Francisco, California

27. Trivedi P, Hematti P. Derivation of SSEA4-/CD73+ mesenchymal stem cells from human embryonic stem cells. 48th Annual meeting of the American Society of Hematology, December 2006; Orlando, Florida

28. Kim YJ, Hussein NL, Hematti P, Hong BK, Calmels B, Donahue RE, Hanawa H, Nienhuis AW, Dunbar CE. Long-term polyclonal and stable gene transfer into rhesus repopulating hematopoietic stem cells using a Simian immunodeficiency virus-based lentiviral vector system. 48th Annual meeting of the American Society of Hematology. December 2006; Orlando, Fl

29. Trivedi P, Hematti P. Derivation and immunological characterization of MSCs from human ESCs”. 13th Annual meeting of the International Society for Cellular therapy. June 2007; Sydney, Australia

30. Laurila J, Laatikainen L, Castellone MD, Hinkkanen A, Hematti P, Laukkanen M. Enhanced angiogenesis in rat hind limb ischemia after local infusion of human embryonic stem cell-derived mesenchymal stem cells. XVth congress of the European Society of Gene and Cell Therapy. October 2007; Rotterdam, The Netherlands

31. Laurila J, Laatikainen L, Hematti P, Laukkanen M. Enhanced angiogenesis in rat hind limb ischemia after local infusion of hESC-derived MSCs. XI Annual Meeting of the American Society of Gene Therapy. May 2008; Boston, Massachusetts

32. Kim J, Hematti P. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. 38th Annual Scientific Meeting, ISEH - Society for Hematology and Stem Cells. September 2009; Athens, Greece

33. Lushaj EB, Haworth R, Hematti P, Kohmoto T. Cardiac mesenchymal stromal cells promote growth of adult stem cells in vitro. V World Stem Cell Summit. September 2009; Baltimore, Maryland

34. Kim J, Hematti P. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. 51th American Society of Hematology Meeting. December 2009; New Orleans, Louisiana

35. Hanson SE, Kleinbeck KR, Kim J, Faucher LD, Kao WJ, and Hematti P. Local delivery of mesenchymal stem cells for cutaneous wound healing in a porcine model.” International Foundation of Adipose Therapeutics and Science (IFATS) Meeting, October 2010; Dallas, Texas

36. Hanson SE, Kleinbeck KR, Kim J, Faucher LD, Kao, WJ, Hematti P. Local delivery of mesenchymal stem cells for cutaneous wound healing in a porcine model. Midwestern Burn Association Conference, November 2010; Madison, Wisconsin

37. Hanson SE, Kleinbeck KR, Kim J, Faucher LD, Kao WJ, Hematti P. Local delivery of mesenchymal stem cells for cutaneous wound healing in a porcine model. American Medical Association 34th Interim Meeting, November 2010; San Diego, California

38. Costanzo ES, Juckett MB, Sheerar D, Becker TL, Nelson AM, Schell K, Hematti P, Coe, C L. Distress and social support predict immune recovery following hematopoietic stem cell transplantation. 69th Annual Meeting of the American Psychosomatic Society. March 2011; San Antonio, Texas

39. Hanson SE, King SN, Kim J, Chen X, Thibeault SL, Hematti P. Immunomodulatory properties of a mesenchymal stem cell-hydrogel scaffold. 56th Annual Meeting of the Plastic Surgery Research Council. April 2011; Louisville, Kentucky

40. Costanzo, ES, Juckett MB, Sheerar D, Becker TL, Nelson AM, Schell K., Hematti P, Coe CL. Predictors of immune recovery following hematopoietic stem cell trans transplantation. 18th Annual Meeting of the PsychoNeuroImmunology Research Society, June 2011; Chicago, Illinois

41. Kim J, Hematti P. Breast Tissue Stromal Cells Preferentially Promote Generation of M2 Macrophages: A Novel Mechanism for Tumor Supportive Properties of Breast Microenvironment. Department of Defense, Breast Cancer Research Program, Era of Hope Conference. August 2011; Orlando, Florida

42. Bloom D, Emler C, Drier D, Sheerar D, Schell K, Centanni J, Hei D, Hematti P. Characterization of Bone Marrow-Derived Mesenchymal Stromal Cells Grown in Different Culture Media. 64th AABB Annual Meeting. October 2011; San Diego, California

43. DeSantes K, Delgado D, Hanks J, Leath C, McDowell K, Hematti P, Sondel. Haploidentical Stem Cell Transplantation for Treatment of Children with Refractory Neuroblastoma. 4th International Tübingen-Symposium on Pediatric Solid Tumors. February 2012; Tübingen, Germany

44. Costanzo ES, Juckett MB, Nelson AM, Erdmann AA, Rathouz PJ, Hematti P, Coe CL. Immune responses contribute to depression, fatigue, and pain in blood and marrow transplant recipients. Annual Meetings of the American Society of Blood and Marrow Transplantation. February 2012; San Diego, California

45. Costanzo ES, Juckett MB, Nelson AM, Erdmann A, Rathouz PJ, Hematti P, Coe CL. Immune responses contribute to depression, fatigue, and pain in hematopoietic stem cell transplant recipients. 36th Annual Meeting of the American Society of Preventive Oncology: March 2012; Washington, DC

46. Hope C, Hebron E, Kim J, Jensen J, Flanagan C, Bhatia N, Leith C, Maroulakou I, Mitsiades CS, Miyamoto S, Callander N, Hematti P, Asimakopoulos F. Molecular Pathways That Determine the Activation State of Macrophages within the Myeloma Niche. 54th American Society of Hematology Meeting. December 2012; Atlanta, Georgia

47. Gupta A, Kim J, Hope C, Jensen J, Callander N, Hematti P, Bresnick EH, Schwartz DC, Asimakopoulos F. Optical Mapping of the Myeloma Cancer Genome to Elucidate Mechanisms of Acquired Resistance to Proteasome Inhibitors. 54th American Society of Hematology Meeting. December 2012; Atlanta, Georgia

48. Costanzo ES, Juckett MB, Nelson, AM, Hematti P, Rathouz PJ, Sheerar D, Ersland K, Coe CL. Biobehavioral influences on recovery following hematopoietic stem cell transplantation. 71st Annual Meeting of the American Psychosomatic Society. March 2013; Miami, FL

49. Rathouz PJ, Asimakopoulos F, Juckett MB, Coe CL, Sheerar D, Ersland K, Hematti P, Costanzo ES. Recovery of Natural Killer Cells and Monocyte Subsets Following Autologous Peripheral Blood Stem Cell Transplantation Predicts Longer Progression Free Survival Among Multiple Myeloma Patients. 55 American Society of Hematology Meeting. December 2013; New Orleans, Louisiana

50. Runaas L, Longo WL, Juckett M, Borcherding W, Hematti P, Cook RJ. The Utility of Monitoring Chimerism: More Predictive for Nonablative Regimens? 55 American Society of Hematology Meeting. December 2013; New Orleans, Louisiana

51. Callander NS, Rathouz PJ, Asimakopoulos F, Juckett MB, Coe CL, Sheerar D, Ersland K, Hematti P, Costanzo ES. Recovery of Natural Killer Cells and Monocyte Subsets Following Autologous Peripheral Blood Stem Cell Transplantation Predicts Longer Progression Free Survival Among Multiple Myeloma Patients. 55 American Society of Hematology Meeting. December 2013; New Orleans, Louisiana

52. Costanzo ES, Rathouz, PJ, Juckett MB, Coe CL, Schwartz JR, Hematti P, & Callander NS. Anxiety and posttraumatic growth predict progression-free and overall survival following autologous stem cell transplantation for multiple myeloma. Poster presented at the 72nd Annual Meeting of the American Psychosomatic Society. March 2014; San Francisco, CA

53. Cantu DA, Rose WE, Hematti P, Kao WJ. Encapsulated Mesenchymal stromal/stem Cell and Leukocyte Immunomodulation Had Nominal Impact on the Elimination of Established Staphylococcus Aureus Biofilms. The Society for Biomaterials Annual meeting. April 2014; Denver, Co

54. Hanley PJ, Mei ZY, Durett A, Bloom D, Hematti P, Savitz SI, Gee AP. Large-scale expansion of human bone marrow-derived MSCs to treat patients after stroke. 17th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT). May 2014; Washington, DC

55. Erdmann ML, Juckett M, Longo WL, Coe CL, Moore H, Hematti P, Costanzo ES. Effects of acute graft-versus-host-disease on physical and psychological functioning following hematopoietic stem cell transplantation. American Society of Clinical Oncology Meeting. May-June 2014; Chicago IL

56. AA Erdmann, Juckett M, Coe CL, Rathouz PJ, Longo WL, Nelson AM, Hematti P, Costanzo ES. Inflammation and depression in allogeneic stem cell transplant recipients. American Society of Clinical Oncology Meeting. May-June 2014; Chicago IL

57. Kempton S, Haynes L, Gan-Jankowska E, Forrest L, Hematti P, Fernandez L, Burlingham W, Strober S, Kaufman D. Cellular Based Immunodepletion and Tomotherapy for Induction of Immunosuppression in a Rhesus Macaque Renal Allotransplant Model. World Transplant Congress July 2014; San Francisco, Ca

58. Callander NS, Walter LL, Juckett MB, Kenkre VP, Hematti P, McMannes J, Evans RK, Eckstein LA, Gage B. Utilization of Leftover Autologous Peripheral Blood Stem Cells (PBSCs) in Patients with Multiple Myeloma (MM). 56 American Society of Hematology Meeting. December 2014; San Francisco, California

59. Cuiffo BG, Campagne A, Bell GW, Lembo A, Orso F, Lien E, Bhasin MK, Raimo M, Hanson SE, Marusyk A, Hematti P, Polyak K, Mariani O, Volinia S, Vincent-Salomon A, Taverna D, Karnoub AE. Mesenchymal stem cell regulated microRNAs converge on the speech gene FOXP2 and regulate breast cancer metastasis. 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium, December 2014, San Antonio, TX

60. Haynes LD, Haynes WJ, Kempton S, Jankowska-Gan E, Fernandez L, D'Alessandro T, Lisa Forrest, Bloom D, Hematti P, Burlingham WJ, Kaufman DB. Induction of Tolerance to Kidney Transplants in Rhesus Macaque. UW-Madison Department of Surgery 6th Annual Research Summit. January 2015; Madison, Wisconsin

61. Costanzo ES, Hematti P, Callander NS, Coe CL, Juckett MB, Arevalo J, Ma J, Kim J, Nelson AM, Cole SW. Depression and social attachment predict CD14+ monocyte gene expression profiles among individuals with multiple myeloma undergoing autologous stem cell transplantation. American Psychosomatic Society Meeting. March 2015; Savannah, Georgia

62. Stroncek DF, Jin P, Reems JO, Cancelas J, Nayak R, Shaw G, O'Brien T, McKenna Jr DH, Armant M, Silberstein L, Gee AP, Hei DJ, Hematti P, Civini S, Sabatino M, Robey PG. Comparison of bone marrow stromal cell (BMSC) production methods and products from multiple centers. International Society for Cell Therapy Annual Meeting, May 2015; Las Vegas, NV

63. Eslani M, Hamouie J, Ying, HY, Hematti P, Djalilian., AR. A Reproducible in Vitro Assay to Measure Immunomodulatory Properties of Mesenchymal Stem Cell on the Corneal Epithelial Cells. Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology. May 2015; Denver, CO

64. Bouchlaka MN, Kim J, Bloom DD, Hematti P, Capitini CM. Human mesenchymal stem cell-educated macrophages: a potential therapy for GVHD and radiation injury. The American Association of Immunologists Annual Meeting, May 2015; New Orleans, LA

65. DeSantes K, Otto M, Delgado D, Hank J, McDowell K, Leith C, Hematti P, Sondel P. Reduced Intensity Haploidentical Transplantation with NK Cell Infusions for Pediatric Acute Leukemia and High Risk Solid Tumors. 4th International Conference on Immunotherapy in Pediatric Oncology. September 2015; Seattle, WA

66. Haynes LD, Haynes WJ, Kempton S, Jankowska-Gan E, Bloom D, Fernandez L, D'Alessandro T, Forrest L, Hematti P, Burlingham WJ, Kaufman DB. Induction of Tolerance To Kidney Transplants in Rhesus Macaque. UW-Madison Department of Surgery 7th Annual research Summit, Jan 2016. Madison, WI

67. Coonen J, Haynes L, Brunner K, Post J, Hematti P, Kaufman D. Optimization of Apheresis in Rhesus Macaques (Macaca mulatta). UW-Madison Department of Surgery 7th Annual research Summit, Jan 2016. Madison, WI

68. Vrooman L, Millard H, Brazauskas R, Majhail N, Battiwalla M, Flowers M, Savani B, Akpek G, Aljurf M, Bajwa R, Baker KS, Beitin A, Bitan M, Buchbinder D, Dandoy C, Gale RP, Hayashi RJ, Hematti P, Kamble RT, Kasow KA, Kletzel M, Lazarus H, Malone AK, O’Brien T, Olsson R, Reddy V, Reikes J, Ringen O, Schears RM, Seo S, Steinberg A, Yu LC, Shaw B, Duncan C. Survival and Late Effects of Children Undergoing Myeloablative Allogeneic HCT At Less Than Three Years of Age: A Report from the Center for International Blood and Marrow Transplant Research. Annual Meetings of the American Society of Blood and Marrow Transplantation. February 2016; Honolulu, HA

69. Muffly L, Pasquini MC, Martens M, Brazauskas R, Zhu X, Adekola K, Aljurf MD, Artz AS, Bajel A, Ballen KK, Battiwalla M, Beitinjaneh A, Cahn J, Carabasi M, Chen Y, Chhabra S, Ciurea SO, Copelan EA, D'Souza A, Edwards J, Freytes CO, Fung HC, Gale RP, Giralt SA, Hashmi SK, Hematti P, Hildebrandt GC, Ho VT, Jakubowski AA, Lazarus HM, McCarthy PL, Olin RL, Olsson R, Rezvani A, Rizzieri DA, Seftel M, Seo S, Sorror ML, Szer J, Wood WA. Increasing Use of Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients Age 70 Years and Older: A CIBMTR Study of Trends and Outcomes. Annual Meetings of the American Society of Blood and Marrow Transplantation. February 2016; Honolulu, HA

70. Muir P, Hans E, Racette M, Volstad N, Sample S, Schaefer S, Bleedorn J, Hao Z, Suresh M, Hematti P. Autologous Bone Marrow-Derived Mesenchymal Stromal Cells Elicit an Anti-Inflammatory Response in a Canine ACL Rupture Model. Orthopaedic Research Society Annual Meeting. March 2016; Orlando, Fl

71. Bleedorn J, Hans E, Racette M, Volstad N, Sample S, Schaefer S, Hao Z, Marulasiddappa S, Hematti P, Muir P. Autologous Bone Marrow-Derived Mesenchymal Stromal Cells Elicit an Anti-Inflammatory Response in a Canine Partial Rupture Model. Submitted to 43rd Annual Veterinary Orthopedic Society Conference. February- March, 2016; Sun Valley, ID

72. Djalilian AR, Ghassemi S, Agnihotri G, Hamouie J, Tadepalli A, Putra I, Shen X, Hematti P, Eslani M. Rate of Proliferation in Corneal Limbal versus Bone Marrow Mesenchymal Stem Cells. Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), May 2016; Seattle, WA

73. Eslani M, Movahedan A, Putra I, Hamouie J, Tadepalli A, Shen X, Afsharkhamseh N, Ghahari E, Hematti P, Djalilian AR. The Effect of Bone Marrow Mesenchymal Stem Cell Secretome on Corneal Epithelial Wound Healing. Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), May 2016; Seattle, WA

74. Hamouie J, Eslani M, Ghassemi S, Agnihotri G, Tadepalli A, Ghahari E, Hematti P, Djalilian AR. Comparative Effects of Corneal Limbal Versus Bone Marrow Derived Mesenchymal Stem Cell Secretome on Innate Immune Response of Corneal Epithelium. Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), May 2016; Seattle, WA

75. Putra I, Agnihotri G, Ghassemi S, Hamouie J, Tadepalli A, Shen X, Hematti P, Eslani M, Djalilian AR. Human Corneal Limbal Stromal Cells provide a source of Mesenchymal Stem Cells. Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), May 2016; Seattle, WA

76. Tadepalli A, Eslani M, Hamouie J, Agnihotri G, Ghassemi S, Putra I, Afsharkhamseh N, Hematti P, Djalilian AR. Immunomodulatory Gene Expression Profile of Corneal-Limbal Versus Bone Marrow derived Mesenchymal Stem Cells. Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), May 2016; Seattle, WA

77. Guerra AD, Johnathan Macnulty, Hematti P, Rose WE, W. Kao J. Hydrogels loaded concurrently with mesenchymal stromal/stem cells and antimicrobials promote cutaneous wound healing and decrease Staphylococcus aureus biofilm. Submitted to: 10th World Biomaterials Congress, May 2016; Montreal, Canada

78. Bleedorn JA, Hans EC, Racette M, Volstad N, Sample SJ, Heaton C, Holzman G, Schaefer SL, Bloom D, Hao Z, Amene E, Suresh M, Hematti P, Muir P. Autologous bone marrow-derived mesenchymal stem cells elicit an anti-inflammatory response in dogs with cruciate rupture. Submitted to American College of Veterinary Surgeons (ACVS) Surgery Summit, October 2016; Seattle, WA

79. Sabloff M, Wang T, Zhu X, Artz AS, Adekola K, Abraham A, Auletta JJ, Battiwalla M, Beitinjaneh A, Bredeson CN, Bufarull RM, Cahn JY, Cerny J, Chhabra S, Copelan EA, Daly A, Dias A, Diaz MA, Freytes CO, Gale RP, Ganguly S, Hale GA, Hamilton BK, Hashmi SK, Hematti P, Hildebrandt GC, Holmberg LA, Hong S, Lazarus HM, Lazaryan A, Luger SM, Muffly L, Nagler A, Nishihori T, Norkin M, Olsson R, Perales MA, Rashidi A, Romee R, Saad A, Seo S, Ulrickson ML, Ustun C, Wirk, BM, Woolfrey AE, Yared J, Pasquini MC, Shin Mineishi S. Impact of Higher-Dose Total Body Irradiation Conditioning on Outcome of an Allogeneic Hematopoietic Cell Transplant (HCT) in the Modern Era. Submitted to Annual Meetings of the American Society of Blood and Marrow Transplantation. February 2017; Orlando, FL

80. Guerra AD, Rose WE E, Hematti P, Kao WJ. Minocycline enhances the mesenchymal stromal/stem cell pro-healing phenotype in triple antimicrobial-loaded hydrogels for inoculated cutaneous wound healing. Submitted to: Society for Biomaterials Conference April 2017 Annual meeting, Minneapolis, MN. Accepted for a talk presentation

81. Djalilian AR, Kink J, Hamouie J, Tadepalli A, Putra I, Shen X, Hashemi H, Hematti P, Eslani M. The Effect of Mesenchymal stromal cells on macrophage immunophenotype. Submitted to ARVO-The Association for Research in Vision and Ophthalmology May 2017 Annual meeting, Baltimore, MD

82. Agnihotri G, Ghassemi S, Putra I, Shen X, Sheth J, Eslani M, Hematti P, Djalilian AR. The Effect of Lipopolysaccharide on TSG6 Expression in Mesenchymal Stromal Cells. Submitted to ARVO-The Association for Research in Vision and Ophthalmology May 2017 Annual meeting, Baltimore, MD

83. Putra I, Eslani M, Hamouie J, Tadepalli A, Shen X, Desai V, Hematti P, Djalilian AR. The Effect of Human Corneal-Derived Mesenchymal Stromal Cells Secretome on the Human Macrophages Viability. Submitted to ARVO-The Association for Research in Vision and Ophthalmology May 2017 Annual meeting, Baltimore, MD

84. Eslani M, Putra I, Shen X, Hamouie J, Tadepalli A, Movahedan A, Afsharkhamseh N, Ghahari E, Hematti P, Djalilian AR. Corneal-Limbal Mesenchymal Stromal Cell Secretome is Antiangiogenic in Vitro. Submitted to ARVO-The Association for Research in Vision and Ophthalmology May 2017 Annual meeting, Baltimore, MD. Winner of Member In Training (MIT) Outstanding Poster Award Competition

85. Capitini CM, Bouchlaka MN, Moffitt A, Kim J, Kink J, Bloom D, Love C, Dave S, Hematti P. Human MEMs are a distinct high IL-6 producing macrophage subset with anti-inflammatory and radioprotective properties in vivo. Submitted to: American Association of Immunologists-AAI May 2017 Annual Meeting, Washington, D.C.

86. Haynes LD, Post J, Haynes WJ, Jankowska-Gan E, Bloom D, Fernandez L, D'Alessandro T, Redfield III R, Forrest L, Hematti P, Burlingham WJ, Strober S, Kaufman DB. Induction of Tolerance to Kidney Transplants in Rhesus Macaques. Submitted to American Transplant Congress April-May 2017 Meeting, Chicago, IL

87. Deming DA, Hope C, Emmerich P, Pagenkopf A, Matkowskyj K, Van DeHey D, Payne S, Clipson L, Callander NS, Hematti P, Miyamoto S, Johnson MG, Asimakopoulos F. Versican proteolysis as a key regulator of CD8+ T-cell infiltration in colorectal cancer. American Society of Clinical Oncology (ASCO) Annual Meeting June 2017, Chicago, IL

88. Rentscher KE, Broman A, Coe CL, Juckett MB, Rathouz P, Hematti P, Costanzo ES. Biomarkers associated with risk and recovery in cancer patients after hematopoietic stem cell transplantation. Submitted to 24th Annual Psychoneuroimmunology Research Society (PNIRS) Scientific Meeting; June 2017, Galveston, Tx

89. Guerra AD, Rose WE, Andes D, Hematti P, Kao WJ. Minocycline enhances the antimicrobial capacity of unpolarized macrophages against Acinetobacter baumannii while inducing an anti-inflammatory profile. IDWeek, October 2017, San Diego, Ca

90. Brunstein C, Pasquini M, Soyoung K, Fei M, Artz A, Battiwalla M, Bejanyan N, Gale RP, Hematti P, Lahoud OB, de Lima M, Reshef R, Rotz S, Savani B, Schouten HC, Mineishi S, Rogosheske J, Perales MA. The effect of conditioning regimen dose reduction in obese patients undergoing autologous transplantation. Submitted to 59th American Society of Hematology Meeting. December 2017; Atlanta, Georgia

91. Pagenkopf A, Dhakal B, Hope CL, Papadas A, Johnson MG, Nagel B, Kurudza E, Partha S, Ruffolo B, Leith C, Miyamoto S, Hematti P, Hari P, Callander NS, Asimakopoulos F. Versican (VCAN) Proteolysis Predicts T-Cell Infiltration in Myeloma Bone Marrow Post- Autologous Stem Cell Transplant (ASCT). Submitted to 59th American Society of Hematology Meeting. December 2017; Atlanta, Georgia

92. Chamberlain CS, Clements AEB, Kink J, Choi U, Hematti P, Vanderby R. Human Exosome Educated Macrophages Stimulates Early Tendon Healing. Accepted for oral presentation at: Orthopaedic Research Society; March 2018. New Orleans, LA

93. Gahvari ZJ, Callander NS, Coe CL, Juckett MB, Asimakopoulos F, Hematti P, Erin S. Costanzo. Prognostic Significance of Circulating IL-6, Tnfα, and IL-10 for Multiple Myeloma Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation. 25th Annual American Society of Blood and Marrow transplantation. Feb 2018, Salt Lake City, UT

94. Kenkre VP, Juckett MB, Bradley K, Grindle K, Burkholder J, Nechville J, Callander NS, Hall AC, Longo WL, Hematti P. Engraftment and Immune Reconstitution Outcomes after Alpha/Beta T Cell and CD 19 + B Cell Depletion with Haploidentical Transplantation in Adult Patients with Lymphoma. 25th Annual American Society of Blood and Marrow transplantation. Feb 2018, Salt Lake City, UT

95. Zhubin J. Gahvari, Jens Eickhoff, Aric C. Hall, Hematti P, Mark B. Juckett, Vaishalee P. Kenkre, Walter L. Longo, Natalie S. Callander. Failure of Levofloxacin Prophylaxis to Alter Incidence of Neutropenic Fever in Multiple Myeloma Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation. 25th Annual American Society of Blood and Marrow transplantation. Feb 2018, Salt Lake City, UT

96. Ninos C, Jared J, Mably M, Michael Reed M, Hutson P, Williams Z, Callander NS, Hall AC, Hematti P, Juckett MB, Longo WL, Kenkre VP. Outcomes of BeEAM (bendamustine, etoposide, cytarabine, melphalan) Compared to BEAM (carmustine, etoposide, cytarabine, melphalan) for High Dose Chemotherapy Followed by Autologous Stem Cell Transplant. 25th Annual American Society of Blood and Marrow transplantation. Feb 2018, Salt Lake City, UT

97. Zinter MS, Logan BR, Zhu X, Sapru A, Abraham A, Aljurf MD, Arnold SD, Artz A, Auletta JJ, Chhabra S, Copelan E, Duncan C, Fretham C, Gale RP, Guinan E, Hematti P, Keating AK, Marks DI, Savani BN, Olsson R, Ustun C, Williams KM, Pasquini MC, Dvorak CC. Improved Mortality Prognostication for Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results From a Virtual Pediatric Systems (VPS) and Center for International Blood and Marrow Transplant Research (CIBMTR) Database Merger. 25th Annual American Society of Blood and Marrow transplantation. Feb 2018, Salt Lake City, UT

98. Rentscher KE, Broman AT, Coe CL, Juckett MB, Rathouz PJ, Hematti P, Carroll JE, Costanzo ES. Behavioral and biological predictors of chronic graft-versus-host disease and mortality following hematopoietic stem cell transplantation. Accepted for oral presentation at the 76th Annual Scientific Meeting of the American Psychosomatic Society. March 2018; Louisville, KY

99. Spinali K, Schmuck EG, Walker S, Dhillon A, Kink J, Bloom D, Hematti P, Raval AN. Novel Cardiac Fibroblast-derived Extracellular Matrix Educates Monocytes into Alternatively Activated Macrophages with Low Inflammatory Marker Expression. American College of Cardiology Annual Meeting. March 2018, Orlando, FL

100. Samaeekia R, Eslani M, Putra I, Rabiee B, Shen X, Park YJ, Hematti P, Djalilian AR. Role of Human Corneal Mesenchymal Stromal Cell-derived Exosomes in Corneal Epithelial Wound Healing. ARVO 2018 Annual Meeting. April 2018; Honolulu, Hawaii

101. Kaufman DB, Haynes L, Burlingham W, Hematti P, Forrest L, Post P, Jankowska-Gan E, Jensen K, Strober S. Tomotherapy and Hematopoietic Stem Cells for Tolerance to Kidney Transplants in Rhesus Macaques. 27th International Congress of the Transplantation Society; June 2018; Madrid, Spain

102. Kaufman DB, Haynes L, Hematti P, Burlingham W, Forest L, Post J, Redfield R, Fernandez L, D'Alessandro A, Haynes J, Jensen K, Strober S. Tomotherapy and Donor Hematopoietic Cells for Tolerance to Kidney Transplants in Rhesus Macaques. American Transplant Congress. June, 2018; Seattle, Washington

103. Chamberlain CS, Clements AEB, Kink JA, Choi U, Pederson JD, Hematti P, Vanderby R. Exosome Educated Macrophages Improve Tendon Healing Compared to Exosomes. poster presentation. Orthopaedic Research Society Tendon Section Meeting. November 2018: Portland, Oregon

104. Solomon SR, Martin AS, Shah NN, Fatobene G, Al Malki M, Ballen KK, Bashey A,i Bejanyan N, Bolaños-Meade J, Brunstein CG, Defilipp Z, Champlin RE, Fuchs EJ, Hamadani M, Hematti P, Kanakry CG, McGuirk JP, McNiece IK, Ciurea SO, Pasquini MC, Rocha V, Romee R, Patel SS, Vasu S, Waller EK, Wingard JR, Zhang M, Eapen M. T-Replete Haploidentical Cell Transplantation Using Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome: Effect of Transplant Conditioning Regimen Intensity on Outcomes (oral). American Society of Hematology Meeting. December 2018, San Diego, CA

105. Tanimura N, Liao R, Wilson GM, Dent MR, Cao M, Burstyn JN, Hematti P, Liu X, Zhang Y, Zheng Y, Keles S, Xu J, Coon JJ, Bresnick EH. GATA/Heme Multi-Omics Reveals a Trace Metal-Dependent Erythrocyte Developmental Mechanism (Oral Presentation). American Society of Hematology Meeting. December 2018, San Diego, CA

106. D'Angelo CR, Hall AC, Kim K, Mattison RJ, Longo WL, Hematti P, Callander NS, Juckett M. A Phase II Study of Decitabine Followed By Allogeneic Hematopoietic Stem Cell Transplantation in High-Risk Patients with Myeloid Malignancies (Poster Presentation). American Society of Hematology Meeting. December 2018, San Diego, CA

107. Chamberlain CS, Clements AEB, Kink JA, Choi U, Pederson JD, Hematti P, Vanderby R. Exosome Educated Macrophages Improve Tendon Healing Compared to Exosomes. Oral presentation. Annual meeting of Orthopaedic Research Society. Feb 2019: Austin, Texas

108. Gahvari ZJ, Lasarev M, Eickhoff JC, Hall AC, Hematti P, Juckett MB, Kenkre VP, Callander NS. Severe Obesity Does Not Worsen Transplantation Outcome in Multiple Myeloma. NCCN Annual Meeting. March 2019, Orlando, Florida

109. Costanzo ES, Nelson AM, Juckett MB, Coe CL, Hematti P, Rumble ME. Long-Term sleep disruption following hematopoietic stem cell transplantation: Relevance and biobehavioral predictors. 77th Annual Scientific Meeting of the American-Psychosomatic-Society on Body to Mind. Vancouver, Canada, March 2019

110. Putra I, Shen X, Nguyen T, Rabiee B, Anwar KN, Afsharkhamseh N, Jabbehdari S, Yazdanpanah G, Eslani M, Joslin C, Dana R, Hematti P, Djalilian AR. Pre-Clinical Evaluation of the Safety of Subconjunctivally Injected Bone Marrow Mesenchymal Stem Cells in Rodents and Rabbits. ARVO 2018 Annual Meeting. April 2019: Vancouver, Canada

111. Jabbehdari S, Yazdanpanah G, Putra I, Anwar KN, Shen X, Rabiee B, Eslani M, Hematti P, Djalilian AR. Efficient Expansion of Corneal Mesenchymal Stromal Cells with Preserved Therapeutic Effects. ARVO 2018 Annual Meeting. April 2019: Vancouver, Canada

112. Pytel N, McDowell K, Desantes K, Capitini C, Hematti P, Leith C, Sondel P, Otto M. TCRαβ/CD19 Depleted Haplo-HSCT + Zoledronate for pediatric malignancies: Preliminary findings. American Society of Pediatric Hematology/Oncology (ASPHO) Meting. May 2019: New Orleans, Louisiana

113. Rentscher KE, Cole SW, Carroll JE, Coe CL, Hematti P, Kim J., Juckett MB, Lamkin DM, Costanzo ES. Social Attachment Predicts Inflammatory and Anti-Viral Signaling in Individuals Undergoing Autologous Hematopoietic Stem Cell Transplantation. 26th Annual Scientific Meeting of the Psychoneuroimmunology Research Society. June 2019, Berlin, Germany

114. Gahvari ZJ, Lasarev M, Eickhoff JC, Hall AC, Hematti P, Juckett MB, Kenkre VP, Callander N. Severe Obesity Does Not Worsen Transplantation Outcome in Multiple Myeloma. 17th International Myeloma Workshop, September 2019, Boston, Massachusetts

115. Destrampe E, Connor J, Hematti P, Raife T. Are Heritable Red Blood Cell Parameters Transferred from Donor to Recipient in Stem Cell Transplantation? A Retrospective Review of an AML/MDS Cohort at a Tertiary Care Hospital. 2019 AABB Annual Meeting. October 2019, San Antonio, Texas

116. Pasquini M, Hu ZH, Zhang YY, Grupp, S, Hematti P, Jaglowski S, Keating A, Nikiforow S, Philips C, Pulsipher M, Shah S, Steinert P, Yanik G, Wang HL, Horowitz M, Bleikardt E. Real World Experience of Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cells Targeting CD19 in Patients with Acute Lymphoblastic Leukemia (ALL) and Diffuse Large B-Cell Lymphoma (DLBCL) Using the Center for International Blood and Marrow Transplant Research (CIBMTR) Cellular Therapy (CT) Registry. Society of Hematologic Oncology 2019 Annual Meeting. September 2019, Houston, Texas

117. Papadas A,, Flietner E, Morrow Z, Wiesner J, Cicala A, Pagenkopf A, Hope CL, Rajagopalan A, Wen Z, Emmerich P, Deming D, Miyamoto S, Hematti P, Callander NS, Rakhmilevich A,Otto M, Capitini CM, Zhang J, Asimakopoulos F. Versican Proteolytic Fragments (Matrikines) Regulate the Intratumoral Dendritic Cell Milieu In Vivo: Implications for in Situ Tumor Vaccination. (Poster Presentation) 61st Annual American Society of Hematology Meeting. December 2019, Orlando, Florida

118. D'Angelo C, Sudakaran S, Hematti P, Asimakopoulos F, Augustine C, Safdar N, Callander NS. Impact of Antibiotics on Gut Microbiota Diversity and the Results of a Prospective Dietary Assessment in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation. (Poster Presentation) 61st Annual American Society of Hematology Meeting. December 2019, Orlando, Florida

119. Dhakal B, Mushtaq MU, Cunningham A, Papadas A, Pagenkopf A, Wiesner J, Leith C, Hematti P, Hari P, Callander NS, Asimakopoulos F. Versican (VCAN) Proteolysis Predicts Survival in Multiple Myeloma (MM) after High Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT/AHCT). (Poster Presentation) 61st Annual American Society of Hematology Meeting. December 2019, Orlando, Florida

120. Jaglowski S, Hu ZH, Zhang Y, Kamdar M, Ghosh M, Lulla P, Sasine J, Perales MA, Hematti P, Nikiforow S, Steinert P, Jeschke M, Yi L, Chawla R, Pacaud L, Horowitz MM, Bleickardt E, Pasquini MC. Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Adults with Diffuse Large B-Cell Lymphoma (DLBCL): Real World Experience from the Center for International Blood & Marrow Transplant Research (CIBMTR) Cellular Therapy (CT) Registry. (Oral Presentation) 61st Annual American Society of Hematology Meeting. December 2019, Orlando, Florida

121. Pasquini MC, Locke FL, Herrera AF, Siddiqi T, Ghobadi A, Komanduri KV, Hu ZH, Dong H, Hematti P, Nikiforow S, Steinert P, Purdum A, Horowitz MM, Hooper M, Kawashima J, Jacobson CA. Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, Axicabtagene Ciloleucel (Axi-Cel), for the Treatment of Large B Cell Lymphoma (LBCL) in the United States (US). (Oral Presentation) 61st Annual American Society of Hematology Meeting. December 2019, Orlando, Florida

122. Grupp S, Hu ZH, Zhang Y, Keating A, Pulsipher MA, Philips C, Margossian SP, Rosenthal J, Salzberg D, Schiff DE, Yanik G, Curran KJ, Harris AC, Hematti P, Nikiforow S, Steinert P, Yi L, Chawla R, Horowitz MM, Bleickardt E, Pasquini MC. Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Children and Young Adults with Acute Lymphoblastic Leukemia (ALL): Real World Experience from the Center for International Blood and Marrow Transplant Research (CIBMTR) and Cellular Therapy (CT) Registry. (Poster Presentation) 61st Annual American Society of Hematology Meeting. December 2019, Orlando, Florida

123. Bennani NN, Maurer MJ, Nastoupil LN, Jain MD, Chavez JC, Cashen AF, Dahiya S, LJ Lekakis, Reagan PM, Oluwole OO, McGuirk JP, Deol A, Sehgal AR, Goy A, Hill BT, Vu K, Andreadis C, Munoz J, Rapoport AP, Vose JM, Miklos DB, Locke FL, Neelapu SS, Lin Y. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Cellular Therapies. (Oral Presentation) 61st Annual American Society of Hematology Meeting. December 2019, Orlando, Florida

124. Chamberlain CS, Wildenauer LA, McCaughey M, Kink JA, Hematti P, Vanderby R. Exosome Educated Macrophages Improve Ligament Healing. (Moderated Potser Presentation with award). Orthopaedic Resaerch Society Annual Meeting. February 2020, Phoenix, Arizona

125. D'Angelo CR, Sudakaran S, Asimakopoulos F, Hematti P, Augustine C, Safdar N, Callander NS. Impact of Antibiotics on Gut Microbiota Diversity and the Results of a Prospective Dietary Assessment in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation. American Society for Transplanation and Cellular Therapy Meeting. February 2020, Orlando, Florida

126. Costanzo ES, Hematti P, Coe CL, Knight JM, Juckett MB. Prevalence and Biobehavioral Predictors of Early and Long-Term Fatigue Following Hematopoietic Stem Cell Transplantation. Oral Presentation. American Society for Transplanation and Cellular Therapy Meeting. February 2020, Orlando, Florida

127. Avigan DE, Shah N, Logan B, Zhu J, Bisharat L, Callander MS, Chodon T, Dhakal B, Efebera YA, Geller N, Hematti P, Herman M, Lazarus HM, McKenna Jr DH, Nelson C, Nooka A, O'Brien K, O'Donnell LC, Rapoport AP, Rosenblatt J, Soiffer RJ, Stroopinsky D, Torka P, Uhl L, Waller EK, Wu J, Young JW, Pasquini MC, Chung DJ. Evaluation of Tumor Vaccine Generation in a Phase II Multicenter Trial of Single Autologous Hematopoietic Cell Transplant (AutoHCT) Followed By Lenalidomide Maintenance for Multiple Myeloma (MM) with or without Vaccination with Dendritic Cell/ Myeloma Fusions (DC/MM fusion vaccine): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 1401. Oral Presentation. American Society for Transplanation and Cellular Therapy Meeting. February 2020, Orlando, Florida

128. Sethakorn N, Kosoff D, Heninger E, Soto JM, Yu JQ, Das R, Jarrard D, Galipeau J, Hematti P, Dehm S, Beebe DJ, Lang JM. A multicellular, microfluidic model of the human bone marrow niche in metastatic cancers. AACR Special Conference on the Evolving Landscape of Cancer Modeling. March 2020. San Diego, CA

129. Papadas A, Flietner E, Morrow Z, Wiesner J, Cicala A, Pagenkopf A, Hope C, Emmerich P, Deming D, Zhang J, Hematti P, Callander N, Rakhmilevich A, Otto M, Capitini C, Asimakopoulos F. Versican proteolytic fragments (matrikines) synergize with STING agonists to elicit robust anti-tumor CD8+ T cell responses. Oral Presentation, AACR Annual Meeting. April 2020, San Diego, California (Virtual Meeting due to COVID-19).

130. Roy S, Spinali K, Schmuck EG, Kink J, Hematti P, Raval AN. Cardiac fibroblast derived matrix-educated macrophages express VEGF and IL-6, and recruit mesenchymal stromal cells. American Heart Association Annual Meeting November 2020, (Virtual).

131. Lee CJ, Wang T, Chen K, Spellman SR, Kitko C, MacMillan ML, Pidala JA, Auletta JJ, Badawy S, Battiwalla M, Bhatt VR, Buchbinder D, Cahn JY, DeFilipp Z, Diaz MA, Farhadfar N, Gadalla ZM, Gale RP, Hashem H, Hashmi SK, Hematti P, Hong S, Hossain N, Inamoto Y, Kamble RT, Kumar A, Lekakis LJ, Modi D, Patel S, Savani B, Sharma A, Solomon SR, Verdonck L, Arora M, Couriel DR.. Impact of Chronic Graft-Versus-Host Disease on First Late Effect Among Adult Survivors of Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis. TCT/Transplantation & Cellular Therapy Meeting, February 2021 (Virtual).

132. Muhammad UmairMushtaq, Harrington AM, Chaudhary SG, Michaelis LC, Carlson KS B, Abedin S, Runass L, Callander NS, Juckett MB, Hall AC, Hematti P, Mattison RJ, Atallah EL, Guru Murthy GS. Prognostic Significance of Minimal/Measurable Residual Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia. Poster Presentation at TCT/ Transplantation & Cellular Therapy Meeting, February 2021 (Virtual).

133. Lee CJ, Wang T, Chen K, Spellman SR, Kitko C, MacMillan ML, Pidala JA, Auletta JJ, Badawy S, Battiwalla M, Bhatt VR, Buchbinder D, Cahn JY, DeFilipp Z, Diaz MA, Farhadfar N, Gadalla ZM, Gale RP, Hashem H, Hashmi SK, Hematti P, Hong S, Hossain N, Inamoto Y, Kamble RT, Kumar A, Lekakis LJ, Modi D, Patel S, Savani B, Sharma A, Solomon SR, Verdonck L, Arora M, Couriel DR. First Late Effect in Pediatric Survivors with Chronic Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation for Hematologic Malignancy. TCT/ Transplantation & Cellular Therapy Meeting, February 2021 (Virtual).

134. D'Angelo CR, Sudakaran S, Asimakopoulos F, Hematti P, Safdar N, Callander NS. The Gut Microbiome Is Shaped By Pre-Transplant Dietary Intake, Damaged By Broad-Spectrum Antibiotic Exposure, and Is Associated with Response to Autologous Stem Cell Transplantation in Patients with Multiple Myeloma. Oral Presentation at TCT/ Transplantation & Cellular Therapy Meeting, February 2021 (Virtual).

135. Foster MA, Juckett MB, Hematti P, Costanzo ES. Psychological and Physical Function in Allogeneic Hematopoietic Cell Transplant Survivors with Chronic Graft-Versus-Host Disease. TCT/ Transplantation & Cellular Therapy Meeting, February 2021 (Virtual).

136. Foster MA, Juckett MB, Hematti P, Costanzo ES. Psychological and Physical Function in Allogeneic Hematopoietic Cell Transplant Survivors with Chronic Graft-Versus-Host Disease. Poster Presentation at the Annual Meeting of the American Psycho-Oncology Society, March 2021 (Virtual).

137. Nguyen-Truong M, Kim S, Doherty C, Frederes M, Kaonis S, Ghosh S, Hematti P, Wagner W, Wang Z. Stiffness and anisotropy dependent proangiogenic potential of mesenchymal stromal cells. Summer Biomechanics, Bioengineering and Biotransport Conference June 2021 (Virtual).

138. Capitini CM, Kink JA, Bellio MA, Forsberg MH, Ong IM, Hematti P. Clinical scale production of exosomes from mesenchymal stromal cells to effectively treat military-related tissue injuries. The 2021 Military Health System Research Symposium (Virtual). August 2021, Kissimmee, FL.

139. Capitini CM, Kink JA, Bellio MA, Forsberg MH, Chinnadurai R, Hematti P. Exosomes from Mesenchymal Stromal Cells Primed with a Synthetic Toll-like Receptor 4 Agonist are an Effective Treatment of Hematopoietic Acute Radiation Syndrome. The 2021 Military Health System Research Symposium (Virtual). August 2021, Kissimmee, FL

140. Mushtaq MU, Shahzad M, Zafar MU, Arslan M, Tariq E, Fatima N, Bokhari SS, Shahani J, Anwar I, Chaudhary SG, Singh AK, Abhyankar S, Callander NS, Hematti P, McGuirk JP. Outcomes with Mismatched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis. Poster presentation at: American Society of Hematology 63RD Annual Meeting, December 2021, Atlanta, GA

141. Mushtaq MU, Shahzad M, Shah AY, Zafar MU, Tariq E, Hamid A, Serwat A, Anwar I, Chaudhary SG, Ahmed N, Abhyankar S, Callander NS, Hematti P, McGuirk JP. Outcomes with Natural Killer Cells Infusion after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis. Poster presentation at: American Society of Hematology 63RD Annual Meeting, December 2021, Atlanta, GA

142. Shahzad M, Faisal MS, Tariq E, Hussain A, Arslan M, Thammineni V, Syed L, Karam A, Anwar I, Chaudhary SG, Ahmed N, Lin TL, Abhyankar S, Hematti P, McGuirk JP, Mushtaq MU. Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-Analysis. Poster presentation at: American Society of Hematology 63RD Annual Meeting, December 2021, Atlanta, GA

143. Shahzad M, Chaudhary SG, Tariq E, Fatima N, Arslan M, Zafar MU, Shah AY, Ahmed M, Anwar I, Ahmed N, Shune L, Balusu R, Hematti P, McGuirk JP, Mushtaq MU. Outcomes with Mismatched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation Following Reduced Intensity Conditioning: A Systematic Review and Meta-Analysis. Poster presentation at: American Society of Hematology 63RD Annual Meeting, December 2021, Atlanta, GA

144. Iqbal Q, Shahzad M, Tariq E, Hashim L, Basit A, Zaidi K, Faisal MS, Anwar I, Chaudhary SG, Balusu R, Ahmed N, Shune L, Hematti P, McGuirk JP, Mushtaq MU. Outcomes with Hematopoietic Stem Cell Transplantation in Secondary Hemophagocytic Lymphohistiocytosis: A Systematic Review and Meta-Analysis. Poster presentation at: American Society of Hematology 63RD Annual Meeting, December 2021, Atlanta, GA.

145. Hess NJ, Turicek D, Hudson A, Hematti P, Gumperz J, Capitini CM. Differentiation of a CD4/CD8αβ Double Positive T Cell Population from the CD8 Pool Is Both Predictive and Sufficient to Mediate Graft-Vs-Host Disease. Poster presentation at: American Society of Hematology 63RD Annual Meeting, December 2021, Atlanta, GA.

146. Chung DJ, Shah N, Stroopinsky D, Wu J, Bisharat L, Callander N, Logan B, Anderson K, Chodon T, Dhakal B, Devine S, Efebera Y, Geller G, Hemati P, Holmberg L, Howard A, Johnson B, Lazarus H, Malek E, McCarthy P, McKenna D, Mendizabal A, Munshi N, O’Donnell L, Rapoport AP, Nooka A, Reese J, Soiffer R, Uhl L, Cheloni G, Karagkouni D, Vlachos IS, Young J, Rosenblatt J, Waller EK, Pasquini MC, Avigan D. Impact of Autologous Hematopoietic Cell Transplant (HCT) followed by Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance on Increasing Multiple Myeloma (MM)-Specific Immunity. Oral presentation at: American Society of Hematology 63RD Annual Meeting, December 2021, Atlanta, GA

147. Park JH, Nikiforow S, Kim S, Hu ZH, Moskop A, Ahmed S, Bilal Abid M, Badar T, Bredeson C, Brown V, Cairo MS, Díaz M, Dholaria B, Ganguly S, Grover NS, Hanna R, Hematti P, Kohorst MA, Lazarus H, Lekakis LJ, Locke FL, Murthy HS, Mussetti A, Pulsipher MA, Qayed M, Reshef R, Rizzieri DA, Salas MQ, Savani BB, Sharma A, Schultz KR, Thakar M, Turtle C, Yared JA, Wagner JL, Qiu X, Pasquini MC, and Perales MA. Impact of Allogeneic Hematopoietic Cell Transplantation (HCT) As Consolidation Following CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for Treatment of Relapsed Acute Lymphoblastic Leukemia (ALL). Poster presentation at: American Society of Hematology 63RD Annual Meeting, December 2021, Atlanta, GA

148. Shahzad M, Gull Chaudhary S, Hussain A, Tariq E, Iqbal Q, Rahman RU, Anwar I, Ahmed N, Abhyankar S, Hematti P, McGuirk JP, Mushtaq MU. Outcomes with Allogeneic Hematopoietic Stem Cell Transplantation in TP53-Mutated Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis. Poster Presentation at Tandem Meetings/ Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, February 2022, Salt Lake City, UT.

149. Shahzad M, Gull Chaudhary S, Iqbal Q, Tariq E, Hussain A, Altaf S, Anwar I, Ahmed N, Abhyankar S, Hematti P, McGuirk JP, Mushtaq MU. Outcomes with Allogeneic Hematopoietic Stem Cell Transplantation in TP53-Mutated Myelodysplastic Syndromes: A Systematic Review and Meta-Analysis. Poster Presentation at Tandem Meetings/ Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, February 2022, Salt Lake City, UT

150. Shahzad M, Iqbal Q, Tariq E, Inam F, Khan MS, Hussain M, Chaudhary SG, Anwar I, Abhyankar S, Hematti P, Callander NS, Ahmed N, Shune L, McGuirk JP, Mushtaq MU. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Primary Plasma Cell Leukemia: A Systematic Review and Meta-Analysis. Poster Presentation at Tandem Meetings/ Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, February 2022, Salt Lake City, UT

151. Iqbal Q, Shahzad M, Tariq E, Khan H, Hussain M, Inam F, Gull Chaudhary S, Anwar I, Abhyankar SH, Hematti P, Callander N, Ahmed N, Shune L, McGuirk JP, Mushtaq MU. Outcomes of Autologous Stem Cell Transplantation in Primary Plasma Cell Leukemia: A Systematic Review and Meta-Analysis. Poster Presentation at Tandem Meetings/ Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, February 2022, Salt Lake City, UT.

152. Venkata Thammineni, Moazzam Shahzad, Maha A. Hassan, Muhammad H. Khan, Atif Khan, Ali Hussain, Saba Ahmed, Zobia Hussain, Iqra Anwar, Sibgha Gull Chaudhary, Nausheen Ahmed, Sunil H. Abhyankar, Natalie S. Callander, Joseph P. McGuirk, Hematti P, and Muhammad Umair Mushtaq. Impact of CD34+ Graft Cell Dose on Outcomes after Allogeneic Peripheral Blood Stem Cell Transplantation: A Systemic Review and Meta-Analysis. Poster Presentation at Tandem Meetings/ Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, February 2022, Salt Lake City, UT.

153. Chung DJ, Shah N, Stroopinsky D, Wu J, Bisharat L, Callander NS, Logan B, Anderson KC, Dhakal B, Devine SM, Efebera Y, Geller N, Hematti P, Holmberg LA, Howard A, Johnson BD, Lazarus HM, Malek E, McCarthy PL, McKenna DH, Mendizabal A, Munshi NC, O'Donnell LC, Rapoport AP, Nooka A, Reese JS, Soiffer RJ, Uhl L, Cheloni G, Karagkouni D, Vlachos I, Young J, Rosenblatt J, Waller EK, Pasquini MC, Avigan DE. Dendritic Cell/Multiple Myeloma (MM) Fusion Vaccine with Lenalidomide Maintenance after Autologous Hematopoietic Cell Transplant (HCT) Induces MM-Specific Immunity, BMT CTN 1401. Tandem Meetings/ Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, February 2022, Salt Lake City, UT.

154. Hess NJ, Nadiminti K, Hematti P, Capitini CM. Interim Analysis of T Cell Specific Predictive Biomarkers of Graft-Vs-Host Disease and Relapse Following Post Transplant Cyclophosphamide Prophylaxis. Best Oral Abstract Presentation at Tandem Meetings/ Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, April 2022, Salt Lake City, UT.

155. Costanzo ES, Nelson AM, Coe CL, Knight JM, Hematti P, Juckett MB. Prevalence and biobehavioral predictors of early and long-term fatigue following hematopoietic stem cell transplantation. Oral presentation at the Annual Meeting of the American Psychosomatic Society, March 2022 Long Beach, California.

156. Hansen JL, Juckett MB, Foster MA, Rumble ME, Morris KE, Hematti P, Costanzo ES. The influence of chronic graft-versus-host disease on psychological and physical function in allogeneic hematopoietic cell transplant patients. Poster presentation at the Annual Meeting of the American Psychosomatic Society, March 2022 Long Beach, California.

157. Hansen JL, Rumble ME, Coe CL, Foster MA, Juckett MB, Dickson DA, Morris KE, Hematti P, Costanzo ES. Biobehavioral mechanisms underlying psychological and physical function in cancer patients with chronic graft-versus-host disease. Poster presentation at the Annual Meeting of the American Psychosomatic Society, March 2022 Long Beach, California.

158. Margolis M, Jung R, Tu G, An S, Dana R, Jeng BH, Basu S, Rosenblatt M, Hematti P, Mahmud N, Joslin CE, Djalilian Phase I Study of the Safety of Locally Delivered Allogeneic Mesenchymal Stem Cells for Promoting Corneal Repair: Early Results. ARVO Annual Meeting, May 2022, Denver, Colorado.

159. Wilson N, Reese SR, Ptak L, Aziz F, Parajuli S, Jucaud V, Denham S, Mishra A, Hematti P, Djamali A. Ixazomib for Desensitization (IXADES): Results of a Phase II Clinical Trial. American Transplant Congress, Boston, MA, June 2022.

160. Soukup A, Matson D, Liu P, Johnson K, Hematti P, Bresnick E. Noncoding genetic variation as a determinant of hematopoietic stem cell mobilization efficacy. 51st Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH), September 2022. Edinburgh, Scotland.

161. Nguyen-Truong M, Kim S, Ghosh S, Hematti P, Chinnadurai R, Wagner WR, Wang Z. Pro-angiogenic potential of mesenchymal stromal cells regulated by matrix stiffness and anisotropy mimicking right ventricles. Summer Biomechanics, Bioengineering and Biotransport Conference June 2022, Eastern Shore, MD.

162. Greenbaum U, Hashmi H, Elsawy M, Kim S, Moskop A, Awan FT, Farooq U, Ganguly S, Hematti P, Jain MD, Kebriaei P, Locke FL, Mead E, Nishihori T, Olson AL, Pennisi M, Perales MA, Geethakumari PR, Shouval R, Shpall EJ, Magalhaes-Silverman M, Strouse C, Turtle CJ, Vallurupalli A, Wudhikam K, Pasquini MC, Ahmed S, and Sorror M. Prognostic Impact of Comorbidities on Outcomes of Patients (pts) with Relapsed or Refractory Large B-Cell Lymphoma (r/r LBCL) Treated with Chimeric Antigen Receptor T-Cell Therapy (CART). Poster Presentation, American Society of Hematology 64th Annual Meeting, December 2022, New Orleans, Louisiana.

163. Mirza A, Hosing C, Foss FM, Kim S, Moskop A, Oloyede T, Ahmed S, Hematti P, Turtle CJ, Pasquini MC, and Gowda L. Impact of Age on Outcomes after CD19 Directed CAR T Cell Therapy for Large B Cell Lymphomas: Real World Experience from the Center for International Blood & Marrow Transplant Research (CIBMTR). Poster Presentation, American Society of Hematology 64th Annual Meeting, December 2022, New Orleans, Louisiana.

164. Jiang P, Prabahar A, Kink JA, Hematti P, Vanderby R, Walczak B, Chamberlain CS. Modulating The MSC Microenvironment Alters Exosome Content And Ligament Healing Capacity. Poster Presentation at Orthopedic Research Society 2023 Annual Meeting February 2023, Dallas, Texas.

165. Hussain A, Shahzad M, Abbas S, Khan J, Mushtaq AH, Khalild MF, Ud Din MD, Anwar I, Chaudhary SG, Hematti P, Abhyankar SH, McGuirk JP, Mushtaq MU. Outcomes with Allogeneic Hematopoietic Stem cell Transplantation in NPM1-Mutated Acute Myeloid Leukemia: A Systematic Review And Meta-Analysis. Poster Presentation at Tandem Meetings of ASTCT™ and CIBMTR® February 2023, Orlando, Florida.

166. Shahzad M, Ilyas U, Ud Din MA, Park R, Tariq E, Iqbal Q, Chaudhary SG, Anwar I, Hematti P, Abhyankar SH, McGuirk JP, Mushtaq MU. Outcomes after HLA-Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation with Post- Transplant Cyclophosphamide for Graft-Vs-Host Disease Prophylaxis: A Systematic Review and Meta-Analysis. Poster Presentation at Tandem Meetings of ASTCT™ and CIBMTR® February 2023, Orlando, Florida

167. Hess J, Kink J, Rosenkrans Z, Forsberg M, Capitini CM, Hernandez R, Hematti P. Exosomes from Crx-527 Stimulated MSCs Suppress T Cell Activation and Xenogeneic Gvhd While Preserving GVL. Oral Presentation at Tandem Meetings of ASTCT™ and CIBMTR® February 2023, Orlando, Florida.

168. Chang AY, Soleimani M, Jung R, Tu G, Dana R, Jeng BH, Hematti P, Mahmud N, Tu EY, Joslin CE, Djalilian AR. Phase I Study on the Safety of Locally Delivered Allogeneic Mesenchymal Stem Cells for Promoting Corneal Repair. ARVO Annual Meeting, April 2023 New Orleans, LA.

169. Forsberg MH, Kink JA, Bellio MA, Lobo A, Thickens AS, Lewis BM, Ong IM, Khan A, Capitini CM, Hematti P. Clinical scale production of exosomes from mesenchymal stromal cells to effectively treat hematopoietic acute radiation syndrome. Oral Presentation at International Society of Extracellular Meeting, May 2023, Seattle, Washington.

170. Jiang P, Kink JA, Prabahar A, LiK, Mueller E, Yopp S, Hematti P, Vanderby R, Chamberlain CS. Exosomes as a Non-Surgical, Customizable, Cell-Free Therapy to Accelerate Musculoskeletal Healing. Oral Presentation at Military Health System Research Symposium (MHSRS), August 2023, Kissimmee, Florida.

171. Kink JA, Forsberg MH, Chinnadurai R, Hematti P, Capitini CM. Off-the-shelf extracellular vesicle-based therapy generated by a synthetic TLR4 agonist to treat hematopoietic acute radiation syndrome. Oral Presentation at Military Health System Research Symposium (MHSRS), August 2023, Kissimmee, Florida.

172. Karagkouni D, Cheloni G, Torres D, Chung D, Shah N, Callander N, Chodon T, Efebera Y, Geller N, Hematti P, Lazarus H, Malek E, McCarthy P, Nooka A, Rosenblatt J, Rapoport A, Soiffer R, Bisharat L, Stroopinsky D, Waller E, Pasquini M, Vlachos I, Avigan D. Dendritic cell/myeloma fusion vaccine with lenalidomide maintenance following autologous hematopoietic cell transplant (HCT) results in long-term sustained T cell activation and clonotypic expansion. International Myeloma Society 20th Annual Meeting. 27-30 September 2023 • Megaron Athens International Conference Centre Athens, Greece.

173. Wilcox DA, Armant M, Malec L, Shi Q, Johnson BD, Xu H, Du LM, Duffy LJ, Bushman FD, Jerkins JH, Hematti P, Brazauskas R, Jobe SM, Hari PN, Eapen M. Gene Therapy Expressing Platelet Derived Factor VIII for Correction of Hemophilia A with a History of Inhibitors. Poster Presentation at 65th America Society of Hematology Meeting, December 2023, San Diego, California.

174. Shah NN, Furqan F, Szabo A, Kearl T, Zamora A, Neumann J, Hari PN, Schneider D, Longo W, Hematti P, Johnson BD, Hamadani M, Fenske TS. CAR-T Cell Therapies for Multiple Myeloma and B Cell Lymphomas 30 PM Oral Presentation at 65th America Society of Hematology Meeting, December 2023, San Diego, California.